Past Archives

• February 2026

📊 WebKarobar Daily Market Movers

Welcome to WebKarobar Daily Market Movers, your go-to source for today’s top stock updates in the U.S. and Canada. In this Daily Market Movers report, we highlight the biggest gainers, notable losers, and key reasons why these stocks are moving in the market today. Stay tuned for the most important trends in the market with WebKarobar Daily Market Movers.

Daily Market Movers: US & Canada Top Movers (April 2, 2026)

Sky Quarry Inc. (SKYQ): $5.10 USD, +101.58% (+$2.57 USD), Energy. The stock skyrocketed to $5.10 on April 2, 2026, driven by a global oil price spike that saw Brent crude surge past $112 per barrel following conflicts in the Middle East. The primary catalyst is the massive strategic value of the company’s Foreland Refinery—the only operating refinery in Nevada—as it becomes a critical local supplier amid a regional supply crisis caused by major refinery closures in California. Additionally, the company announced active discussions with regional producers in Nevada and Utah to boost local production, positioning SKYQ as a high-margin, domestic energy hedge against geopolitical risks.

SBA Communications Corp (SBAC): $204.04 USD, +18.93% (+$32.48 USD), Real Estate/Technology. The stock surged to $204.04 on April 2, 2026, marking a significant breakout from its recent trading range. The primary catalyst is a Bloomberg News report indicating that the tower operator is exploring a potential sale of the company. This news follows a period of disciplined capital deployment, including a 13% dividend increase and a $213 million share repurchase program, as the company positions itself for a strategic shift amidst high demand for 5G and AI-related network infrastructure.

Firefly Aerospace Inc (FLY): $32.93 USD, +10.65% (+$3.17 USD), Industrials/Space. The stock climbed to $32.93 on April 2, 2026, extending a multi-day rally fueled by a powerful confluence of space sector catalysts. The primary catalyst is the successful April 1 launch of NASA’s Artemis II mission, which directly validates Firefly’s role in the lunar economy through its Blue Ghost lander and CLPS contracts. Investor sentiment was further bolstered by reports of a landmark SpaceX IPO filing and Firefly’s own Q4 results, which showed a staggering 541% year-over-year revenue growth and a strong cash position of nearly $800 million.

Intel Corp (INTC): $50.38 USD, +4.89% (+$2.35 USD), Technology. The stock climbed to $50.38 on April 2, 2026, extending a massive rally after a nearly 9% surge in the previous session. The primary catalyst is the company’s definitive agreement to repurchase Apollo Global Management’s 49% stake in the Fab 34 joint venture in Ireland for $14.2 billion. This move, seen as a major “de-risking” step for Intel’s balance sheet, signals the company’s growing financial strength and confidence in its manufacturing roadmap. Additionally, reports of a 10% to 15% price hike on server CPUs due to surging AI inference demand and the successful ramp of its 18A process have shifted the market narrative from a turnaround struggle to one of aggressive execution.

Intuitive Machines Inc (LUNR): $23.99 USD, +18.53% (+$3.75 USD), Industrials/Space. The stock jumped to $23.99 on April 2, 2026, hitting a new 52-week high as momentum built following the successful April 1 launch of NASA’s Artemis II mission. The primary catalyst is the company’s critical role in the mission’s navigation and tracking through its Space Data Network (SDN), alongside a transformational 2026 outlook projecting revenue of $900 million to $1 billion—a nearly 5x increase from 2025. This surge is further supported by a massive $943 million backlog and the strategic integration of Lanteris Space Systems, positioning the company as a vertically integrated prime contractor for the burgeoning lunar economy.

Palantir Technologies Inc (PLTR): $148.46 USD, +1.34% (+$1.97 USD), Technology. The stock edged up to $148.46 on April 2, 2026, amid a broader recovery in high-growth tech following signs of de-escalation in global geopolitical tensions. The primary catalyst is a shift in investor focus toward the company’s surging profitability and “undervalued” PEG ratio of 0.96, even as it trades at a high P/E multiple. Sentiment is bolstered by massive business momentum, including a 70% year-over-year revenue jump to $1.41 billion in its latest quarter and a $4.3 billion backlog in total contract value, driven by the rapid enterprise adoption of its Artificial Intelligence Platform (AIP) and the U.S. Army’s “program of record” designation for its Maven AI system.

MP Materials Corp (MP): $49.73 USD, +2.73% (+$1.32 USD), Materials. The stock rose to $49.73 on April 2, 2026, building on momentum from a high-impact strategic update delivered on April 1. The primary catalyst is the company’s announcement that it has successfully produced its first rare earth magnets using commercial-scale machinery, marking a critical milestone in its transition from a miner to a high-value vertically integrated manufacturer. Investor confidence is further bolstered by the “10X” magnet facility expansion in Texas, which is backed by an offtake agreement with the Department of Defense and a guaranteed price floor, shielding the company from market volatility while it scales to meet surging demand for AI and EV infrastructure.

USA Rare Earth Inc (USAR): $15.92 USD, +7.57% (+$1.12 USD), Materials. The stock surged to $15.92 on April 2, 2026, as investors aggressively bought the dip following a recent post-earnings pullback. The primary catalyst is the anticipated April finalization of a $1.6 billion Department of Commerce funding agreement, which, combined with a recently closed $1.5 billion private placement, provides the capital necessary for the company’s fully integrated “mine-to-magnet” strategy. Conviction is being driven by a massive geopolitical tailwind, as the ongoing conflict in Iran has created urgent demand for domestic supply chain security for rare earth elements critical to the defense and EV sectors.

Occidental Petroleum Corp (OXY): $62.97 USD, +1.19% (+$0.74 USD), Energy. The stock edged up to $62.97 on April 2, 2026, as it continues to benefit from a powerful “dual-engine” value proposition. The primary catalyst is the sustained geopolitical premium on domestic oil—with Brent crude holding above $112 per barrel—which disproportionately benefits Occidental’s low-cost Permian Basin production following its $9.7 billion divestiture of OxyChem to Berkshire Hathaway earlier this year. Sentiment is further amplified by the final commissioning of Stratos, the world’s largest Direct Air Capture (DAC) plant in Texas, and persistent speculation that Warren Buffett, who now owns nearly 29% of the company, may exercise warrants to purchase an additional 83.9 million shares at a strike price of approximately $59.62.

CF Industries Holdings, Inc. (CF): $129.97 USD, +1.55% (+$1.99 USD), Materials. The stock rose to $129.97 on April 2, 2026, as North America’s largest nitrogen producer continues to act as a primary beneficiary of global supply shocks. The primary catalyst is the 77% surge in urea prices caused by the effective closure of the Strait of Hormuz, which has severely restricted fertilizer flows from the Middle East. While competitors struggle with energy price spikes, CF is leveraging its structural cost advantage via low-cost U.S. natural gas. Investor sentiment is further supported by the company’s “Blue Point” clean ammonia joint venture, which is scheduled to begin civil work in Q2 2026, and a robust $1.7 billion remaining share buyback authorization.

BigBear.ai Holdings Inc (BBAI): $3.58 USD, +4.68% (+$0.16 USD), Technology. The stock rose to $3.58 on April 2, 2026, finding a floor after a heavy sell-off earlier in the year. The primary catalyst is investor optimism surrounding a return to growth, with 2026 revenue guidance projected between $135 million and $165 million—a 17% increase over 2025. This positive outlook is supported by a robust $385 million contracted backlog and a significantly strengthened balance sheet featuring over $460 million in cash. While the market is monitoring a proposal to double the authorized share count to 1 billion for future financing, recent acquisitions like Ask Sage and CargoSeer have positioned the company to capture surging demand for “Agentic AI” within the U.S. defense and national security sectors.

Tilray Brands Inc (TLRY): $6.55 USD, +6.68% (+$0.41 USD), Healthcare/Consumer Goods. The stock rose to $6.55 on April 2, 2026, as investors reacted to record-breaking third-quarter fiscal results. The primary catalyst is an 11% jump in net revenue to $206.7 million, fueled by a 73% surge in international cannabis sales. While the company reported a mixed quarter with an earnings-per-share miss, the market focused on its narrowed net loss and the strategic acquisition of BrewDog’s UK assets, which positions Tilray as a major global player in the craft beverage and cannabis sectors.

📉 Top Losers – WebKarobar Daily Market Movers

Tesla Inc (TSLA): $360.59 USD, -5.42% (-$20.67 USD), Automotive. The stock fell to $360.59 on April 2, 2026, after releasing disappointing Q1 delivery numbers. The primary catalyst is a 14% drop in vehicle deliveries compared to the previous quarter, raising concerns about slowing demand and rising inventory levels.

PMGC Holdings Inc (ELAB): $5.17 USD, -63.10% (-$8.83 USD), Technology. The stock crashed to $5.17 on April 2, 2026, making it one of the market’s top losers following a period of extreme volatility. The primary catalyst is massive momentum-driven selling and high-volume profit taking after a speculative run-up earlier in the week. Despite the company announcing a new subsidiary, NorthStrive Defense Tech, to focus on autonomous drones and defense systems, investors reacted negatively to the high-risk nature of its capital structure and recent 1-for-6 reverse stock split. The sell-off highlights ongoing concerns over the company’s limited cash runway and significant historical shareholder dilution.

Artelo Biosciences Inc (ARTL): $7.04 USD, -10.20% (-$0.80 USD), Healthcare. The stock dropped to $7.04 on April 2, 2026, continuing a period of high volatility following a massive 230% speculative rally earlier in the week. The primary catalyst for the decline is shareholder dilution following the March 30 closing of an $11 million private placement. While the funding supports the company’s expansion into the glaucoma market and its GLP-1 companion therapy research, the issuance of over 3 million new shares and 6.3 million warrants at an effective price of $3.45 has created significant downward pressure as the market absorbs the new supply.

Daily Market Movers: US & Canada Top Movers (April 1, 2026)

Cycurion Inc. (CYCU): $1.05 USD, +3.96% (+$0.04 USD), Technology. The stock closed at $1.05 on April 1, 2026, following the release of its 2025 financial results which highlighted a strategic shift toward high-margin recurring revenue. The primary catalyst is the company’s continued expansion into the public health sector, recently securing $1.35 million in new annual recurring revenue (ARR) through contracts with a major healthcare government agency and NACCHO. While the company is addressing market volatility caused by an unauthorized press release in mid-March, management confirmed a verified contracted backlog of $112.4 million and remains focused on achieving profitability in 2026 by implementing over $2.2 million in annualized cost efficiencies.

Cyclerion Therapeutics (CYCN): $6.38 USD, +311.61% (+$4.83 USD), Healthcare. The stock skyrocketed on April 1, 2026, after the company announced an all-stock merger agreement with Korsana Biosciences to form a combined entity operating under the Korsana name. The primary catalyst is the concurrent announcement of a heavily oversubscribed $380 million private financing round, which is expected to fund operations into 2029. This capital infusion provides the necessary runway for key clinical readouts in 2027, specifically for its lead programs in amyloid plaque clearance and treatment-resistant depression, effectively resolving long-standing liquidity concerns that had previously pressured the micro-cap biotech’s valuation.

Western Digital Corp (WDC): $297.73 USD, +10.07% (+$27.24 USD), Technology. The stock surged on April 1, 2026, as a massive rotation into AI hardware and storage infrastructure reached a “fever pitch.” The primary catalyst is a blockbuster industry report from Gartner upgrading the storage sector to a “Strong Buy,” highlighting that global capacity for AI “data lakes” is currently 40% undersupplied. Following its successful 2025 spin-off of the SanDisk flash business, Western Digital has solidified its dominance in the high-margin Hard Disk Drive (HDD) market, reporting a total sell-out of its 40TB UltraSMR drives through the end of the 2026 fiscal year to meet insatiable demand from hyperscale cloud providers.

PMGC Holdings Inc. (ELAB): $14.00 USD, +133.72% (+$8.01 USD), Biotechnology. The stock has experienced a massive breakout this week following the release of its 2025 annual report, which revealed a 43% surge in total assets to $12.9 million and a significantly strengthened balance sheet. The primary catalyst for the triple-digit gains is a major clinical update from its subsidiary, NorthStrive Biosciences; the FDA provided preliminary feedback suggesting that existing data for its muscle-preservation probiotic, EL-22, may be sufficient to skip certain early-stage trials and move directly toward a Phase 2 study. This progress, combined with the recent completion of a 1-for-6 reverse stock split and new patent filings for its GLP-1 companion therapies, has triggered a high-volume “short squeeze” and a revaluation of the company’s manufacturing and biotech pipeline.

Axe Compute Inc. (AGPU): $3.56 USD, +117.07% (+$1.92 USD), Technology. The stock more than doubled in a single session following a major commercial update regarding its newly launched GPU-as-a-Service platform. The primary catalyst is the announcement of $12 million in executed enterprise agreements signed within the last 30 days, which are expected to generate approximately $835,000 in monthly recurring income starting in Q2 2026. This rapid monetization of its decentralized AI infrastructure—utilizing architectures like the H100 and B200—marks a successful strategic pivot from its legacy biotechnology operations (formerly Predictive Oncology) to high-demand AI compute services.

Mega Fortune Co Ltd (MGRT): $12.26 USD, +89.78% (+$5.80 USD), Technology. The stock experienced a massive vertical breakout as it approached the $12.50 resistance level, marking its strongest performance since its mid-2025 IPO. The primary catalyst is a significant surge in momentum following the company’s full-year 2025 financial disclosures, which revealed a dramatic revenue jump from $3.3 million to $11.1 million—an increase of over 230%. This exponential growth in their IoT Integration Solution Services, particularly in the GreenTech and low-carbon property management sectors, has attracted intense speculative interest. Despite a recently reported negative operating cash flow, investors are currently focusing on the firm’s triple-digit top-line expansion and its success in securing high-value contracts within the rapidly growing Hong Kong and PRC smart-city infrastructure markets.

System1 Inc. (SST): $5.22 USD, +72.85% (+$2.20 USD), Technology. The stock experienced a massive rally as it regained significant momentum following its Q4 and Full Year 2025 earnings report. The primary catalyst is a “triple beat” scenario: the company reported an EPS of -$1.65, significantly better than the analyst expectation of -$2.02, while demonstrating a 17% reduction in annual GAAP net losses. Despite top-line revenue pressure, investors are reacting to the company’s successful pivot toward higher-margin AI-driven customer acquisition and a 9% increase in annual Adjusted EBITDA to $41.9 million. This profitability shift, combined with a 67% adjusted gross margin in Q4, has triggered a sharp revaluation of the omnichannel marketing platform.

Regencell Bioscience Holdings Ltd (RGC): $33.72 USD, +32.60% (+$8.29 USD), Healthcare. The stock experienced a major surge on April 1, 2026, building on a volatile multi-day rebound. The primary catalyst is short squeeze momentum driven by high short interest and a relatively low float, as retail interest spiked following recent SEC Form 3 filings showing significant insider ownership. Despite the triple-digit gains over the last year and a market cap exceeding $11 billion, the company remains pre-revenue and recently filed a $500 million at-the-market (ATM) equity offering, which had initially caused dilution concerns. Investors are currently weighing the speculative potential of its Traditional Chinese Medicine (TCM) pipeline for ADHD and autism against a “going concern” warning from auditors and an ongoing DOJ subpoena.

Intel Corp (INTC): $48.03 USD, +8.84% (+$3.90 USD), Technology. The stock price increased significantly after Intel spent $14.2 billion to buy back full ownership of a major manufacturing factory in Ireland. The primary catalyst is this large investment, which shows the company is confident in its long-term plan to become a leader in chip making again. Investors are also optimistic because Intel is successfully producing its newest, high-performance chips in large quantities, allowing them to compete more effectively in the growing Artificial Intelligence (AI) and data center markets.

Occidental Petroleum Corp (OXY): $62.23 USD, -4.26% (-$2.77 USD), Energy. The stock price pulled back on April 1, 2026, following a massive 58% rally earlier in the year. The primary catalyst for the drop is a shift in investor sentiment as major analysts, including those at Goldman Sachs and Investing.com’s AI models, flagged the stock as “overvalued” or “stretched” at current levels. Despite the company’s strong performance and successful debt reduction, traders are taking profits due to concerns that the stock price has caught up to its fair value, especially as inflation fears and high interest rates create uncertainty for the broader energy sector.

Exxon Mobil Corp (XOM): $160.78 USD, -5.23% (-$8.88 USD), Energy. The stock price dropped as global oil prices fell from their recent highs. The primary catalyst is a sudden shift in the Middle East, where reports of a possible ceasefire and an end to the conflict in Iran have decreased concerns about oil shortages. This removed the “war premium”—the extra cost added to oil prices due to the risk of supply disruptions in the Strait of Hormuz. Additionally, some investors are selling their shares to take profits after the energy sector’s massive gain earlier this year, while others are concerned about a new report questioning the transparency of the company’s past green energy projects.

Healwell AI Inc (AIDX): $0.77 CAD, -1.28% (-$0.01 CAD), Healthcare. The stock price saw a small decline as it continued to stabilize following its recent 2025 year-end financial report. The primary catalyst is investor reaction to the company’s “record revenue” of $103.8 million (a 427% increase) and its first-ever year of positive “Adjusted EBITDA” (a measure of operational profit). While the company is growing rapidly and winning new contracts in the U.S. and Middle East, some investors remain cautious because the company still reported an overall net loss for the year and has seen its share value diluted over the past 12 months.

Serve Robotics Inc (SERV): $8.41 USD, -0.36% (-$0.03 USD), Technology. The stock price remained relatively flat on April 1, 2026, holding steady after a period of high volatility. The primary catalyst for the stock’s recent activity is the company’s ambitious 2026 outlook, which projects revenue to jump to $26 million—a nearly 10x increase from the previous year. This growth is being driven by the expansion of its autonomous delivery fleet to 2,000 robots and its recent move into the healthcare sector through the acquisition of Diligent Robotics. While investors are encouraged by the 400% revenue growth reported in the latest quarter, the stock faces pressure from high operating expenses and a planned $25 million in capital spending this year to continue scaling its robot network.

Daily Market Movers: US & Canada Top Movers (March 31, 2026)

Apellis Pharmaceuticals Inc. (APLS): $40.23 USD, +135.40% (+$23.14 USD), Healthcare. Shares of the biotech firm skyrocketed today following a definitive merger agreement with Biogen (BIIB). The primary catalyst is the $5.6 billion acquisition ($41 per share in cash), as Biogen moves to consolidate its lead in the Geographic Atrophy (GA) market by acquiring Apellis’s blockbuster drug, Syfovre.

C3.ai Inc. (AI): $8.42 USD, +8.09% (+$0.63 USD), Technology. Shares of the enterprise AI software provider climbed today as the broader tech sector staged a relief rally ahead of the 8:00 PM Tehran deadline. The primary catalyst is a surge in demand for “Sovereign AI” applications and defensive cybersecurity integrations, as global enterprises rush to harden their infrastructure against the specific threats recently directed at major U.S. tech firms.

NVIDIA Corp. (NVDA): $174.40 USD, +5.59% (+$9.23 USD), Technology. Shares of the semiconductor titan surged today as the market staged a high-octane relief rally following rumors of de-escalation in the Middle East. The primary catalyst is the sustained “Sovereign AI” infrastructure race, with investors doubling down on NVIDIA’s dominance in AI chipsets as global governments and enterprises accelerate their transition to independent, high-performance data centers. Despite the recent IRGC “Warning Signals” targeting the tech sector, NVDA continues to lead the 2026 tech recovery, fueled by robust demand for its H200 and Blackwell architectures.

STMicroelectronics N.V. (STM): $34.55 USD, +10.31% (+$3.23 USD), Technology. Shares of the European semiconductor giant surged today as the market rewards “Physical AI” and robotics infrastructure plays. The primary catalyst is the re-ignited enthusiasm for the company’s collaboration with NVIDIA to accelerate global adoption of edge-based AI and industrial automation. Additionally, sentiment was bolstered by recent reports of volume production beginning for China-manufactured STM32 microcontrollers and a positive analyst upgrade from Seeking Alpha, which highlighted the massive upside in data center and robotics opportunities. Investors are positioning ahead of the company’s Q1 2026 earnings report on April 23, where a year-over-year EPS increase of 150% is projected.

Palantir Technologies Inc. (PLTR): $146.28 USD, +6.35% (+$8.73 USD), Technology. Shares of the big-data analytics giant surged today as the company becomes a central figure in the “Sovereign AI” and defensive infrastructure narrative. The primary catalyst is a wave of new government and enterprise contracts for its Artificial Intelligence Platform (AIP), as organizations scramble to harden their data systems following the specific IRGC threats directed at the U.S. tech sector. Investors are viewing Palantir as a “mission-critical” defensive play, as its software is increasingly integrated into global security and logistics frameworks.

BigBear.ai Holdings Inc. (BBAI): $3.52 USD, +15.79% (+$0.48 USD), Technology. Shares of the decision-intelligence firm surged today as the market rewards smaller AI players specialized in defense and national security. The primary catalyst is a spillover effect from the heightened geopolitical tensions in the Middle East, with investors betting on increased federal and commercial demand for BigBear’s predictive analytics and “Sovereign AI” infrastructure solutions. As the IRGC’s “Warning Signals” drive a flight toward defensive tech, BBAI is capturing significant momentum as a high-octane alternative to larger enterprise AI peers.

Trilogy Metals Inc. (TMQ): $5.01 CAD, +10.11% (+$0.46 CAD), Basic Materials. Shares of the copper-focused explorer surged today as the market prices in the company’s Q1 2026 earnings expectations and a strategic pivot toward mine permitting. The primary catalyst is the recent approval of a $35 million program for 2026 by the Ambler Metals joint venture, which targets a critical milestone: the mine permit submission for the world-class Arctic Project in Alaska. Investors are also reacting to the re-establishment of an independent management team and potential expedited federal permitting via the FAST-41 framework, which could significantly accelerate the timeline for bringing the Ambler Mining District into production.

SoundHound AI Inc. (SOUN): $6.87 USD, +13.93% (+$0.84 USD), Technology. Shares of the voice-AI specialist surged today as the market broadens its appetite for conversational intelligence and independent AI interfaces. Analyst Upgrade: Cantor Fitzgerald recently maintained a “Buy” rating and a $15 price target on the stock, citing low market expectations that could lead to further upside. Analysts pointed to SoundHound’s strong execution in cross-selling voice services and the growth potential of its new “Sales Assist” AI agents as key drivers for 2026.

Absci Corp. (ABSI): $3.00 USD, +8.70% (+$0.24 USD), Healthcare. Shares of the generative AI drug discovery company climbed today as investors reacted to a string of positive clinical and operational updates. The primary catalyst is the successful dosing of the first three cohorts in the Phase 1/2a HEADLINE trial for ABS-201, an AI-designed antibody targeting hair regrowth (androgenetic alopecia). Sentiment is further bolstered by the recent appointment of a new Chief Medical Officer from Vertex Pharmaceuticals and a reiterated “Buy” rating from Needham, as the market anticipates preliminary safety and PK data in the first half of 2026.

Celestica Inc. (CLS): $281.68 USD, +9.49% (+$24.41 USD), Technology. Shares of the electronics manufacturing services (EMS) leader jumped today as the market continues to re-rate the company as a top-tier “AI infrastructure” play. The primary catalyst is a surge in demand for the Helios rack-scale AI platform, developed in collaboration with AMD, which is positioning Celestica as a critical bottleneck-solver in the shift from GPU processing to advanced networking. Additionally, investor sentiment was bolstered by a significant board reshuffle, with CEO Rob Mionis set to become Chair, signaling a unified focus on hyperscaler execution ahead of the company’s next earnings report on April 23, 2026.

📉 Top Losers – WebKarobar Daily Market Movers

Chevron Corp. (CVX): $206.90 USD, -1.81% (-$3.81 USD), Energy. Shares of the oil supermajor edged lower today as the market prices in a potential de-escalation of Middle East tensions. The primary catalyst is a wave of profit-taking across the energy sector following “peace rumors” and reports that the U.S. is eyeing an exit from the regional conflict. Despite the daily dip, Chevron remains up nearly 40% YTD, supported by its “fortress” balance sheet and a recent exclusive power supply agreement signed with Microsoft and Engine No. 1. Investors are balancing the short-term cooling of crude prices (WTI at $102.83) against the company’s record-breaking Q1 profit projections and its strategic push into biofuels and renewable natural gas.

Occidental Petroleum Corp. (OXY): $65.00 USD, -1.87% (-$1.24 USD), Energy. Shares of the Warren Buffett-backed producer edged lower today as the energy sector faced a wave of profit-taking following “peace rumors” in the Middle East. The primary catalyst is a tactical retreat in crude prices as traders weigh the 8:00 PM Tehran deadline against potential de-escalation signals. Despite today’s dip, OXY remains a standout performer in 2026, up roughly 58% YTD, fueled by its hedge-free production model and significant debt reduction following the $9.7 billion sale of its OxyChem unit in January. Investors continue to monitor the company’s 1PointFive subsidiary, which recently secured a major carbon removal credit deal with Bain & Company, further solidifying OXY’s leadership in the emerging Direct Air Capture (DAC) market.

Constellation Energy Corp. (CEG): $279.25 USD, -6.48% (-$19.34 USD), Utilities. Shares of the nuclear power giant fell sharply today following an investor day update that “calibrated” the aggressive AI-driven expectations of the past year. The primary catalyst is the company’s full-year 2026 earnings guidance, which was set at $11.00–$12.00 per share, missing the Wall Street consensus of $11.72. While Constellation announced a massive $5 billion share buyback and projected 20% EPS growth through 2029, investors were spooked by the lack of new hyperscaler power deals and reports that the Crane Clean Energy Center (Three Mile Island) restart faces grid interconnection delays until 2031. The selloff reflects a broader market re-rating of the “nuclear-for-AI” trade as regulatory and infrastructure bottlenecks become more apparent.

Daily Market Movers: US & Canada Top Movers (March 30, 2026)

Sigma Lithium Corp. (SGML): $16.52 CAD, +13.38% (+$1.95 CAD), Basic Materials. Shares of the Brazilian-based lithium producer surged today following the company’s Q4 2025 earnings presentation on March 30. The primary catalyst is a combination of “remarkable financial resilience” and a 35% quarter-over-quarter increase in operating cash flow, despite volatile global lithium prices. Investors are reacting positively to Sigma’s aggressive debt reduction—having repaid 35% of its total debt in 2025—and the announcement of new offtake agreements totaling $146 million, which positions the company to return to full profitability in 2026.

PMGC Holdings Inc. (ELAB): $3.56 USD, +113.17% (+$1.89 USD), Industrial/Biotech. Shares of the Newport Beach-based firm more than doubled today on massive volume following its 2025 annual report, which highlighted a 43% surge in total assets to $12.87M. The rally is driven by a aggressive expansion strategy—including the acquisition of three companies and its subsidiary’s new ITAR registration for defense work—combined with progress on its muscle-preservation drug, EL-22, which is moving toward Phase 2 trials.

Occidental Petroleum Corp. (OXY): $66.24 USD, +1.41% (+$0.92 USD), Energy. Shares of the Houston-based oil and gas giant are climbing alongside a broader rally in energy stocks as WTI crude prices surge past $106 per barrel. The stock’s performance is underpinned by a significantly strengthened balance sheet following the $9.7 billion sale of its OxyChem subsidiary to Berkshire Hathaway in early 2026, which allowed the company to slash its principal debt to $15 billion. Investors are also eyeing the upcoming Q2 2026 launch of “Stratos,” the world’s largest Direct Air Capture facility, which marks a major milestone in the company’s transition toward industrial-scale carbon management.

AbraSilver Resource Corp. (ABRA): $11.63 CAD, +5.92% (+$0.65 CAD), Basic Materials. Shares of the silver-gold explorer are rallying following the March 30 announcement of high-grade copper and gold intercepts at its Condoryacu target in Argentina, including 72 meters of 18.7 g/t gold. This follows a major de-risking milestone on March 2, when the flagship Diablillos project received formal approval under Argentina’s RIGI investment regime. The stock is currently benefiting from a combination of positive exploration data and a “Buy” consensus from analysts, who anticipate a definitive feasibility study and a formal construction decision for Diablillos later in 2026.

Unity Software Inc. (U): $20.54 USD, +5.60% (+$1.09 USD), Technology/Software. Shares of the game engine leader are gaining momentum after the company released preliminary Q1 2026 results that shattered previous guidance, projecting revenue up to $508 million. The primary catalyst is the successful rollout of “Unity Vector,” its new AI-driven ad-tech engine, which saw a 15% sequential growth and is significantly boosting margins. Investors are also cheering a major strategic pivot: Unity announced it will sunset the ironSource Ads Network by April 30 and is exploring a $1 billion sale of its China division to refocus on its core “AI Gateway” platform and high-margin Create segment.

CrowdStrike Holdings Inc. (CRWD): $380.06 USD, +2.84% (+$10.48 USD), Technology/Cybersecurity. Shares of the Austin-based security titan are rebounding following a key upgrade from Wolfe Research to “Outperform” with a $450 price target. The primary catalyst is the anticipation of a major AI model release from Anthropic, which analysts believe will drive a wave of vendor consolidation as enterprises seek integrated, platform-based security to defend against increasingly sophisticated “agentic AI” threats. This rally follows a period of concentrated selling pressure in the sector, as investors shift focus back to CrowdStrike’s market-leading position and its updated fiscal year 2026 guidance, which projects net new annual recurring revenue (ARR) growth of at least 50%.

Palo Alto Networks Inc. (PANW): $154.35 USD, +4.99% (+$7.33 USD), Technology/Cybersecurity. Shares of the Santa Clara-based leader in network security surged on Monday, marking their largest single-day percentage increase in nearly a year. The rally is a sharp reversal from a multi-week slump, triggered by investors rotating back into high-growth security stocks following a sector-wide upgrade and bullish sentiment regarding the company’s “platformization” strategy. Despite a year-to-date decline, the stock is currently finding strong support as analysts highlight a healthy 73.5% gross margin and an aggressive 19% projected earnings growth for the coming year, positioning it as a top performer in the Nasdaq 100 during today’s session.

Biogen Inc. (BIIB): $187.57 USD, +2.03% (+$3.73 USD), Biotechnology. Shares of the Cambridge-based biotech firm are rising following a dual-catalyst Monday: the FDA approval of a new high-dose regimen for its blockbuster SMA drug, Spinraza, and positive Phase 2 data for litifilimab in treating cutaneous lupus erythematosus. The new Spinraza dosing is expected to stabilize franchise revenue, while the lupus trial met its primary endpoint with a significant reduction in skin disease activity, prompting a “Buy” reiteration and $210 price target from Jefferies. These developments bolster Biogen’s 2026 outlook as it expands its immunology pipeline and continues the global rollout of its Alzheimer’s treatment, Leqembi.

AstraZeneca PLC (AZN): $193.88 USD, +2.90% (+$5.46 USD), Healthcare. Shares of the Cambridge-based pharmaceutical giant rose sharply on Monday, driven by positive Phase 3 trial results for tozorakimab in treating chronic obstructive pulmonary disease (COPD). The OBERON and TITANIA trials demonstrated that the potential first-in-class IL-33 inhibitor significantly reduced moderate-to-severe exacerbations, a major win after previous trial failures by industry rivals. BofA Global Research reiterated its “Buy” rating following the data, which analysts believe de-risks peak sales estimates of $3–5 billion and reinforces AstraZeneca’s robust 2026-2027 catalyst pipeline.

📉 Top Losers – WebKarobar Daily Market Movers

Kraken Robotics Inc. (PNG.V): $7.53 CAD, -8.17% (-$0.67 CAD), Technology/Defense. Shares of the Newfoundland-based subsea tech firm dropped on Monday following a period of high volatility linked to its massive $615 million acquisition of Covelya Group. While the company recently successfully raised $402.5 million through a subscription receipt offering at $8.50 per share to fund the deal, the stock is currently facing downward pressure as it trades below that offering price. Despite the daily dip, the company continues to expand its leadership team, yesterday announcing the appointment of Don Robertson to the Board and the promotion of John Salama to Chief Information Officer to oversee its scaling global operations.

Planet Labs PBC (PL): $27.89 USD, -9.62% (-$2.97 USD), Technology/Space. Shares of the satellite imaging company are pulling back today after hitting an all-time high of $33.72 last week following a blowout Q4 earnings report. The sharp decline is primarily driven by short-term profit-taking and investor caution over a “step-down” in gross margin guidance for Q1 2027, which management attributed to heavy investments in next-generation satellite fleets and lower-margin service contracts. Despite today’s drop, the company’s long-term outlook remains bolstered by a record $900 million backlog and a growing R&D partnership with Google for AI-powered geospatial data analysis.

Intuitive Machines Inc. (LUNR): $16.35 USD, -6.68% (-$1.17 USD), Technology/Space. Shares of the Houston-based lunar explorer fell for a third consecutive session as investors digest a series of mixed catalysts and broader market volatility. While the company recently secured a landmark $180.4 million NASA contract for its IM-5 mission—marking the first use of its heavy-lift “Nova-D” lander—the stock is facing pressure from a $5.3 million insider sale by Director Kamal Ghaffarian and lingering concerns over a Q4 revenue miss. Despite the ambitious “Lanteris” acquisition and management’s bold projection of $1 billion in revenue for 2026, the stock is currently struggling against technical resistance and a “risk-off” sentiment affecting high-growth space infrastructure names.

MDA Space Ltd. (MDA.TO): $32.82 CAD, -4.92% (-$1.70 CAD), Technology/Space. Shares of the Brampton-based space tech leader fell on Tuesday as investors continued to react to NASA’s recent pivot in the Artemis mission, which includes a “pause” on the Gateway station in its current form. Although MDA management clarified that its multi-year Canadarm3 contract remains secure with the Canadian Space Agency, the news has injected uncertainty regarding the timing of future lunar infrastructure milestones. The stock is also facing a “cool off” period and technical correction after a massive 50% year-to-date surge, compounded by a recent $150 million U.S. IPO and over-allotment exercise that has temporarily increased share supply in a volatile macro environment for growth stocks.

Serve Robotics Inc. (SERV): $7.73 USD, -7.09% (-$0.59 USD), Technology/Robotics. Shares of the NVIDIA-backed autonomous delivery leader are sliding as the stock undergoes a technical correction following a high-volatility month. While the company recently reported record 2025 revenue of $2.7 million—beating its own guidance—and announced a major expansion into the healthcare sector via the acquisition of Diligent Robotics, investors are currently grappling with “risk-off” sentiment in the speculative growth space. Despite today’s dip, the long-term outlook remains aggressive, with management projecting 2026 revenue to surge to $26 million as it scales its Gen3 robot fleet across its Uber Eats and DoorDash partnerships.

Daily Market Movers: US & Canada Top Movers (March 26, 2026)

Tilly’s, Inc. (TLYS): $4.20 USD, +1.20% (+$0.05 USD), Specialty Retail. Shares of the California-based action sports and lifestyle retailer are currently trading near a 52-week high, capping off a massive 75% rally over the last two weeks. The primary catalyst is the company’s “turnaround” momentum following a blowout Q4 2025 earnings report on March 11, where it posted its first profitable fourth quarter since 2021. Investor enthusiasm is being driven by a surge in February comparable store sales (+20.1%) and management’s strategic pivot from store closures to opening new locations in fiscal 2026, supported by $87.8 million in total liquidity and zero debt.

Celcuity Inc (CELC): $114.81 USD, +4.16% (+$4.59 USD), Biotechnology. Shares of the Minneapolis-based clinical-stage oncology company are trading near all-time highs, extending a massive 1,400% rally over the past 18 months. The primary catalyst is the continued de-risking of its lead drug candidate, gedatolisib, following a blowout Q4 2025 earnings update on March 25 that confirmed a robust cash runway of $166 million. Investor enthusiasm is reaching a fever pitch as the company prepares for a transformative mid-2026 FDA PDUFA date for HR+/HER2- metastatic breast cancer, supported by Phase 3 VIKTORIA-1 data that showed an unprecedented 76% reduction in the risk of disease progression. With top-tier analysts at Needham and Craig-Hallum recently hiking price targets toward the $140 range, CELC has evolved from a speculative micro-cap into a high-conviction leader in the precision medicine space.

Occidental Petroleum Corp (OXY): $64.36 USD, +4.06% (+$2.51 USD), Oil & Gas Exploration & Production. Shares of the Houston-based energy giant hit a new 52-week high today, significantly outperforming the broader S&P 500 amid a tech-led market sell-off. The primary catalyst is the surge in Brent crude prices above $108 per barrel due to escalating Middle East tensions, combined with reports that long-time CEO Vicki Hollub is preparing to retire. Investor enthusiasm is further bolstered by a wave of recent analyst upgrades from firms like Mizuho ($72 PT) and HSBC ($68 PT), who cite the company’s aggressive deleveraging—including the completion of the $5.8B OxyChem sale—and its operational outperformance in the Permian Basin as key drivers for 2026.

Exxon Mobil Corp (XOM): $165.43 USD, +1.33% (+$2.17 USD), Integrated Oil & Gas. Shares of the Texas-based energy titan are trading near an all-time high, extending a powerful 55% rally over the last nine months. The primary catalyst is the persistent strength in Brent crude prices, which hit $108 per barrel this week amid escalating geopolitical tensions in the Middle East, specifically involving supply concerns in the Strait of Hormuz. Investor enthusiasm is further fueled by the company’s industry-leading $20 billion share buyback program and record-breaking upstream production from its high-margin assets in Guyana and the Permian Basin, which recently reached a 40-year output peak.

New Gold Inc (NGD): $12.16 CAD, +3.31% (+$0.39 CAD), Gold & Copper Mining. Shares of the Toronto-based intermediate miner are trading near their 2026 highs following a major structural transition for the company. The primary catalyst is the successful completion of the plan of arrangement with Coeur Mining (CDE) on March 20, 2026, where New Gold was acquired in an all-stock deal. Under the agreement, New Gold shareholders received 0.4959 shares of Coeur common stock for each NGD share held. Investor enthusiasm is now centered on the combined entity, which creates a premier North American precious metals producer with projected 2026 free cash flow of $2 billion and significant growth from the Rainy River underground and New Afton C-Zone operations.

Lavras Gold Corp (LGC): $2.20 CAD, +20.22% (+$0.37 CAD), Gold Exploration & Development. Shares of the Toronto-based explorer are seeing a sharp recovery today after a period of consolidation following its January $10 million “bought deal” financing. The primary catalyst is the continued analytical momentum from the February 24 high-grade discovery at the Caneleira Target in southern Brazil, where intercepts included 21.66 g/t gold over 15 metres. Investor enthusiasm is high as the company advances its flagship Butiá-Fazenda do Posto project toward the Preliminary License (LP) application stage, supported by the recent engagement of top-tier engineering firms Ausenco and GE21 to lead the Preliminary Economic Assessment (PEA).

Palo Alto Networks Inc (PANW): $156.36 USD, +2.05% (+$3.14 USD), Cybersecurity Software. Shares of the Santa Clara-based global cybersecurity leader are rebounding today, providing a rare green spot in a volatile Nasdaq session. The primary catalyst is the surge in demand for enterprise-grade defense following a massive wave of state-sponsored cyberattacks reported earlier this week, which has refocused investor attention on the “platformization” strategy PANW launched in late 2024. Despite a broader tech sell-off triggered by rising bond yields, investor enthusiasm is being sustained by the company’s recent Q2 FY2026 earnings beat—highlighted by 33% growth in annual recurring revenue (ARR)—and its aggressive integration of generative AI through its “Prisma” and “Cortex” platforms, which analysts at firms like Jefferies and Wedbush suggest could double the company’s market cap by 2030.

Zscaler Inc (ZS): $141.50 USD, +1.48% (+$2.06 USD), Cybersecurity Software. Shares of the San Jose-based cloud security pioneer are stabilizing today after hitting a new 52-week low of $137.60 earlier in the week. The primary catalyst is a technical “relief rally” as the stock becomes deeply oversold following a 36% year-to-date decline driven by fears of AI-driven disruption in the SaaS sector. Investor enthusiasm is being cautiously rekindled by a “buy the dip” narrative from analysts at firms like Wells Fargo and Scotiabank, who argue that the market has overreacted to hardware-efficiency news (like TurboQuant) and is overlooking Zscaler’s robust 26% year-over-year revenue growth and its role as a “tollbooth” for secure AI agent traffic.

CrowdStrike Holdings Inc (CRWD): $392.62 USD, +1.75% (+$6.76 USD), Cybersecurity Software. Shares of the Austin-based endpoint security leader are outperforming the broader Nasdaq index today, hovering near their 52-week highs despite a general rotation out of high-growth tech. The primary catalyst is the surge in enterprise “platformization” demand following a series of high-profile global ransomware attacks, which has validated CrowdStrike’s Falcon platform as the industry’s gold standard. Investor enthusiasm is further bolstered by the company’s recent Q4 2026 earnings report, which highlighted a record $3.6 billion in Annual Recurring Revenue (ARR) and a 27% year-over-year growth rate, as the market increasingly views CrowdStrike as the primary “AI-native” beneficiary of the shifting cybersecurity landscape.

Altria Group Inc (MO): $64.62 USD, +1.32% (+$0.84 USD), Tobacco & Consumer Staples. Shares of the Richmond-based tobacco giant are snapping a nine-day losing streak today, outperforming the broader consumer staples sector as investors pivot back to defensive, high-yield assets. The primary catalyst is the nationwide retail expansion of on! PLUS nicotine pouches, which officially hit shelves across the U.S. on March 23, 2026, marking a critical milestone in the company’s “Moving Beyond Smoking” transition. Investor enthusiasm is also being supported by the stock’s recent ex-dividend date on March 25; shareholders of record will receive a $1.06 quarterly payout on April 30, maintaining an attractive annualized yield of approximately 6.6% even as the company navigates a leadership transition with CFO Sal Mancuso set to take over as CEO this coming May.

Kodiak Sciences Inc (KOD): $39.76 USD, +74.77% (+$17.01 USD), Biotechnology. Shares of the California-based clinical-stage company are skyrocketing today, hitting a new 52-week high and marking one of the largest single-day gains on the Nasdaq. The primary catalyst is the announcement of positive topline results from GLOW2, the company’s second Phase 3 study of Zenkuda (tarcocimab tedromer) for diabetic retinopathy. The study met its primary endpoint with 62.5% of treated patients achieving a significant improvement in disease severity compared to just 3.3% in the sham group. Investor enthusiasm is explosive as the data demonstrated an 85% risk reduction in sight-threatening complications, leading Kodiak to accelerate its timeline for a Biologics License Application (BLA) submission. This breakthrough follows a period of heavy institutional accumulation by specialist investors like Baker Brothers and Braidwell LP, who have positioned themselves ahead of what is now being viewed as a transformative commercial inflection point for the company’s retinal pipeline.

📉 Top Losers – WebKarobar Daily Market Movers

Market Update: We are hitting the pause button on our “Top Gainers” list for today, Thursday, March 26, 2026. With the Nasdaq tumbling over 2.38% and the S&P 500 seeing its worst day since January, the vast majority of sectors are trading deep in the red. Rather than chasing outliers, we are focusing on the broader “Correction Territory” shift and geopolitical energy impacts. Stay tuned for a full breakdown of the defensive plays holding steady.

Daily Market Movers: US & Canada Top Movers (March 25, 2026)

urban-gro Inc (UGRO): $36.29 USD, +416.95% (+$29.27 USD), Sports Media & Experiential Marketing. Shares of the Colorado-based company transitioned into a massive rally today as the market priced in its radical pivot from legacy agricultural services to a high-growth sports and media platform. The primary catalyst is the successful completion of its merger with Flash Sports and Media Inc., which was paired with a March 9 confirmation that the company has regained full Nasdaq compliance regarding minimum equity and bid price requirements. This momentum is further amplified by a 1-for-25 reverse stock split executed in February, which significantly tightened the share float to approximately 685,000 shares, allowing high demand for the company’s new focus on T20 cricket media rights and global fan experiences to trigger an explosive price correction.

Lightwave Logic Inc (LWLG): $8.59 USD, +16.87% (+$1.24 USD), Photonic Integrated Circuits (PICs). Shares of the Colorado-based technology platform hit a new 52-week high today as investor enthusiasm builds around the company’s transition from a research-phase venture to a validated semiconductor ecosystem partner. The primary catalyst is the continued momentum from a series of high-profile foundry agreements, most notably the March 11 announcement with Tower Semiconductor to integrate Lightwave’s 110 GHz+ electro-optic polymer modulators into Tower’s PH18 silicon photonics platform. This was followed by the March 16 launch of a Process Design Kit (PDK) for GlobalFoundries, which effectively de-risks the technology by allowing tier-one customers to design polymer-enhanced chips for 800G and 1.6T AI data center infrastructure using standard industry tools. While the company reported a net loss of $20.3 million in its recent 10-K, a strengthened cash position of approximately $69 million and a commercial roadmap targeting volume production in 2027 have repositioned the stock as a key “pick-and-shovel” play for the next generation of AI scale-out architectures.

Allbirds Inc (BIRD): $3.57 USD, +6.89% (+$0.23 USD), Sustainable Lifestyle Footwear. Shares of the San Francisco-based footwear innovator gained ground today as the company continues to execute its aggressive “profitable growth” restructuring plan. The primary catalyst is the anticipation surrounding its fourth-quarter and full-year 2025 earnings call, which management officially scheduled for March 31, 2026. Investor sentiment has been buoyed by recent strategic pivots, including the January announcement to close nearly all full-price U.S. stores and transition toward a distributor-heavy international model to slash SG&A costs. Additionally, the February launch of the “Terralux” collection—the industry’s first footwear made from bio-designed plant proteins and recycled tires—is being viewed as a critical test of the brand’s ability to recapture its early innovation-led momentum ahead of next week’s financial update.

BWX Technologies Inc (BWXT): $222.13 USD, +8.48% (+$17.37 USD), Nuclear Energy & Defense. Shares of the Virginia-based nuclear component manufacturer surged to an all-time high today as the market reacted to a convergence of bullish analyst upgrades and expanding project backlogs. The primary catalyst is a major price target increase from BofA Securities, which raised its objective from $230 to $250, citing the company’s “strong nuclear heritage” and indispensable role in both naval propulsion and commercial nuclear sectors. Sentiment was further bolstered by the announcement of a sub-contractor role in the NextGen MURR research reactor project and a $1.5 billion agreement with the National Nuclear Security Administration (NNSA) to enhance domestic uranium enrichment. These wins, alongside a Zacks #1 (Strong Buy) upgrade, reflect growing investor confidence in BWXT’s ability to capitalize on the massive energy demands of AI data centers and the global shift toward small modular reactor (SMR) infrastructure.

Hycroft Mining Holding Corporation (HYMC): $34.47 USD, +3.76% (+$1.25 USD), Gold & Silver Mining. Shares of the Nevada-based explorer continued their recovery today as the market digests the long-term implications of its massive 2025-2026 drilling campaign. The primary catalyst is the recent confirmation that the Brimstone silver system extends at least 150 meters deeper than previously modeled, featuring high-grade intercepts including 1,187 g/t silver over 14.8 meters. Investor confidence has been further bolstered by the company’s strategic shift to prioritize these high-grade underground targets over its legacy low-grade heap leach operations, a move supported by a debt-free balance sheet and a cash position of approximately $194 million. While the stock has faced volatility in March following the postponement of its Preliminary Economic Assessment (PEA) to early 2027, the 55% increase in Measured & Indicated resources reported in February remains a strong fundamental floor for the current valuation.

Advanced Micro Devices Inc (AMD): $220.27 USD, +7.26% (+$14.90 USD), Semiconductors. Shares of the Santa Clara-based chipmaker surged today as the semiconductor sector leads a broader market rally fueled by easing geopolitical tensions in the Middle East. The primary catalyst is a strategic move by both AMD and Intel to implement across-the-board price hikes of 10% to 15% for their CPU product lines, a clear signal of robust pricing power amid a global surge in AI-driven computing demand. Investor sentiment is further electrified by the long-term implications of AMD’s landmark $60 billion AI chip agreement with Meta Platforms and a new strategic MOU with Samsung to secure HBM4 memory for the upcoming “Instinct MI455X” accelerators. This technical breakout to a 4-week high reflects growing conviction that AMD is successfully positioning itself as the premier “open-standard” alternative to Nvidia within the $1 trillion AI infrastructure buildout.

Intel Corp (INTC): $47.18 USD, +7.08% (+$3.12 USD), Semiconductors. Shares of the Santa Clara-based chip giant surged today as the market reacted to a rare combination of aggressive pricing power and a broader “risk-on” rally. The primary catalyst is a report from Nikkei Asia confirming that Intel has informed major PC and server clients of a planned 10% to 15% price hike across its entire CPU lineup, effective at the end of this month. This move is driven by a severe supply-demand imbalance, with lead times for server chips stretching from two weeks to as long as six months as manufacturing capacity is redirected to high-margin AI infrastructure. Investor sentiment was further amplified by a de-escalation in Middle East geopolitical tensions—following a U.S.-led 15-point peace proposal—which sent oil prices lower and triggered a massive recovery in cyclical tech stocks. Additionally, Intel’s launch of the Core Ultra Series 3 “Panther Lake” enterprise chips provided a critical “endorsement” of its 18A process node, signaling to the market that the company’s multi-year manufacturing turnaround is officially ready for high-volume commercial scaling. The recent surge in Intel and the broader semiconductor sector is heavily tied to a dramatic shift in the ongoing U.S.–Iran conflict. While your current gains are being driven by internal factors like CPU price hikes, the “macro” move is all about the “peace talk optimism” currently hitting the headlines.

Trilogy Metals Inc (TMQ): $4.80 CAD, +5.18% (+$0.24 CAD), Copper & Critical Minerals. Shares of the Vancouver-based explorer gained momentum on the TSX today as the company approaches a pivotal month for its flagship Alaskan assets. The primary catalyst is the anticipated end-of-March closing of a $35.6 million strategic investment by the U.S. federal government, a transaction that will see the Department of War (DOW) acquire a 10% stake in the company. Investor sentiment is further buoyed by the 2026 program budget of $35 million approved for the Ambler Metals joint venture, which is set to initiate the formal mine permitting process for the high-grade Arctic Project this year. While the stock has faced headwinds from a wider fiscal 2025 net loss due to non-cash accounting charges related to the U.S. funding, the recent restoration of federal approvals for the Ambler Access Road—a critical 211-mile industrial corridor—has significantly de-risked the project’s path to a final investment decision in 2028.

Arm Holdings plc (ARM): $157.07 USD, +16.38% (+$22.11 USD), Semiconductors. Shares of the UK-based chip architect soared today following the official announcement of its pivot into the merchant silicon market. The primary catalyst is the unveiling of the Arm AGI CPU, a high-performance processor designed for AI data centers, with Meta Platforms signed as the lead partner. This shift from a pure IP-licensing model to selling its own branded chips is expected to massively expand Arm’s revenue base, prompting HSBC and Barclays to hike price targets to $205 and $200. Investors are betting that this “Arm Everywhere” strategy will allow the company to capture a significant share of the $100 billion data center CPU market as the industry moves toward autonomous AI orchestration.

Boralex Inc (BLX): $36.62 CAD, +10.97% (+$3.62 CAD), Renewable Energy. Shares of the Montreal-based power producer surged on the TSX today following the official announcement of a definitive agreement to be taken private. The primary catalyst is a $9.0 billion acquisition deal by Brookfield Asset Management and CDPQ (La Caisse), which offers shareholders $37.25 per share in cash. This price represents a 31.8% premium over the March 20 closing price and follows a week of intense speculation regarding a strategic review. The deal, which has received unanimous board approval, aims to transition Boralex into a standalone private entity to accelerate its “2030 Strategic Plan” and double its installed capacity to 8 GW. With the stock now trading within 2% of the offer price, the market is effectively pricing in a smooth path to the expected Q4 2026 closing, despite a $115 million termination fee.

📉 Top Losers – WebKarobar Daily Market Movers

Micron Technology Inc (MU): $382.09 USD, -3.40% (-$13.44 USD), Semiconductors. Shares of the Idaho-based memory leader faced downward pressure today as investors weighed a breakthrough in AI efficiency against the company’s aggressive spending requirements. The primary catalyst is Google’s release of “TurboQuant,” a new compression algorithm that claims to reduce KV-cache memory requirements for AI models by 6x while increasing speeds. This innovation has sparked concerns that future AI hardware cycles may require less physical DRAM than previously modeled, potentially cooling the “unprecedented” pricing power Micron has enjoyed. This sentiment is compounded by the “hangover” from the March 18 fiscal Q2 earnings report; while Micron delivered a massive beat with $12.20 EPS and $23.86 billion in revenue, the market remains wary of management’s decision to hike fiscal 2026 capex to over $25 billion. Despite a 30% dividend increase and a bullish Q3 revenue guide of $33.5 billion, the stock is seeing a “sell the news” rotation as analysts at Summit Insights and Morgan Stanley warn of intensifying HBM competition from Samsung and the high execution risk associated with Micron’s massive new fabrication projects in Idaho and New York.

SK Hynix Inc (000660): ₩938,000 KRW, -5.73% (-₩57,000 KRW), Semiconductors. Shares of the Icheon-based memory giant fell sharply today, leading a broader decline in South Korean tech heavyweights as the KOSPI index struggled under the weight of foreign selling. The primary catalyst is the market’s “digestion” of Google’s TurboQuant, a new AI compression algorithm that has triggered fears of a structural reduction in high-bandwidth memory (HBM) demand. While analysts at JPMorgan and Morgan Stanley have defended the stock—arguing that improved efficiency typically leads to more total demand (the Jevons Paradox)—investors took the opportunity to lock in profits following the company’s record-breaking 2025 performance reported at yesterday’s Annual General Meeting. Sentiment was further complicated by Samsung’s aggressive ₩110 trillion ($73B) 2026 capex plan aimed at reclaiming HBM leadership, and SK Hynix’s own move to file for a $14.4 billion U.S. IPO later this year to fund its massive “Yongin Cluster” expansion. Despite the day’s pull-back, the company’s confirmation that it is moving toward 3nm logic dies with TSMC for its next-generation HBM4E chips suggests the technical arms race for AI infrastructure remains at a fever pitch.

Draganfly Inc (DPRO): $4.95 USD, -21.80% (-$1.38 USD), Aerospace & Defense. Shares of the Saskatoon-based drone developer plummeted today as the market reacted negatively to the company’s fiscal 2025 year-end results and a significant miss on quarterly expectations. The primary catalyst is a widening comprehensive loss of $22.98 million for the year (compared to $14.06 million in 2024), driven by rising operational expenses and inventory write-downs. While the company reported record annual revenue of $7.73 million—a 17.8% year-over-year increase—investors were spooked by a sharp decline in adjusted gross margins, which fell to 20.4% from 30.9%. This earnings miss, coupled with the recent dilution from a massive $50 million registered direct offering closed in February, has refocused market attention on the company’s high cash burn rate despite its growing portfolio of Canadian defense and AI swarm-tech contracts.

Healwell AI Inc (AIDX): $0.82 CAD, -2.38% (-$0.02 CAD), Healthcare AI. Shares of the Toronto-based healthcare technology company edged lower today as the market continues to process its record-breaking fiscal 2025 year-end results released on March 19. The primary catalyst is the successful transition to a pure-play AI and software model, which delivered a 427% surge in annual revenue to $103.8 million and the company’s first full year of positive Adjusted EBITDA ($2.3 million). Despite this fundamental turnaround and a narrowing Q4 loss of $0.02 per share, the stock remains in a consolidation phase following a 15% decline over the past week. Investor sentiment is balanced between high-growth signals—including a multi-million dollar U.S. health exchange contract and an indirect stake in xAI—and near-term liquidity concerns as the company scales its global “DARWEN” AI platform toward a targeted 10% EBITDA margin exit run-rate in 2026.

Palo Alto Networks Inc (PANW): $153.22 USD, -2.54% (-$3.99 USD), Cybersecurity. Shares of the Santa Clara-based security leader edged lower today, extending a period of underperformance as the company navigates high integration costs and a strategic transition to “platformization.” The primary catalyst is the lingering market reaction to the recent downward revision of the company’s fiscal 2026 EPS guidance, which was cut to a range of $3.65–$3.70 (down from $3.80–$3.90). This reduction is largely attributed to surging costs associated with the integration of CyberArk and Chronosphere, as well as the significant equity dilution from issuing 112 million shares to fund the CyberArk deal. Despite the near-term headwinds, sentiment was partially buoyed by this week’s launch of Prisma AIRS 3.0, a new suite designed to secure “Agentic AI” enterprise workflows, and a fresh $1 billion share buyback authorization. While the stock currently trades near its 52-week low of $139.57, analysts at Wells Fargo recently initiated coverage with an “Overweight” rating, viewing the current price as an attractive entry point for the company’s dominant role in the $300 billion cybersecurity secular trend.

Daily Market Movers: US & Canada Top Movers (March 24, 2026)

Daily Market Movers: US & Canada Top Movers (March 23, 2026)

Palantir Technologies Inc. (PLTR): $160.84 USD, +6.74% (+$10.16 USD), Technology/Software-Infrastructure. Shares of the data analytics giant surged today following a series of mission-critical wins within the U.S. and UK government sectors. The primary catalyst is the Pentagon’s official designation of Palantir’s Maven Smart System as a “program of record,” a milestone that formalizes the AI platform’s use across all branches of the U.S. military and secures long-term funding. Investor sentiment was further bolstered by news of a strategic trial with the UK’s Financial Conduct Authority, which will use the Foundry platform to modernize fraud detection and intelligence analysis.

SoundHound AI Inc. (SOUN): $6.89 USD, +5.19% (+$0.34 USD), Technology/Software-Infrastructure. Shares of the voice AI specialist are gaining momentum today following a flurry of high-profile enterprise partnerships and product reveals in March 2026. The move is anchored by the company’s recent launch of “Employee Assist” at Peet’s Coffee—a voice-AI agent now supporting baristas across their nationwide U.S. retail footprint—and a massive strategic alliance with ManpowerGroup’s Experis to scale agentic AI for large enterprises. Sentiment was further electrified at last week’s NVIDIA GTC 2026, where SoundHound unveiled the world’s first multimodal “Agentic+” platform running entirely on the edge, enabling vehicles to “see and hear” without a cloud connection. Despite a recent CFO transition to the quantum computing sector, investors are looking past management turnover toward SoundHound’s projected $260M revenue floor for 2026 and its dominant position in the rapidly expanding $24B enterprise agentic AI market.

Healwell AI Inc. (AIDX): $0.85 CAD, +4.94% (+$0.040 CAD), Healthcare/Health Information Services. Shares of the Canadian healthcare AI developer are trending higher today following a transformative Q4 and full-year 2025 earnings report. The rally is fueled by the company’s milestone achievement of its first full year of positive Adjusted EBITDA ($2.3M), a massive swing from the $14.2M loss in 2024. Revenue for the year skyrocketed 427% to $103.8M, primarily driven by the successful integration of Orion Health and a surge in adoption for its DARWEN™ AI clinical decision support platform. Investor confidence is further bolstered by a new multi-million dollar U.S. Health Information Exchange contract and the company’s expansion into the Middle East. While shareholders have faced dilution over the past year, the pivot to a “pure-play” AI and SaaS model—validated by 47 peer-reviewed publications—has positioned AIDX as a high-growth leader in the $24B preventative care AI market.

BigBear.ai Holdings Inc. (BBAI): $3.68 USD, +2.94% (+$0.11 USD), Technology/Software-Infrastructure. Shares of the decision intelligence provider are climbing today as the company pivots toward a high-growth 2026 outlook following a challenging fiscal 2025. The uptick is driven by renewed investor confidence in the company’s “mission-ready” AI strategy, highlighted by the recent full conversion of its 2029 convertible notes which has significantly de-leveraged the balance sheet. Following its March 2nd earnings report, management has guided for $135M–$165M in 2026 revenue, representing a robust 17% year-over-year jump. This recovery narrative is supported by a string of high-stakes government wins, including a prototype contract for the DoD’s CDAO to analyze foreign adversarial media and a 10-year $900M USAF IDIQ vehicle. With the successful integration of recent acquisitions like Ask Sage and CargoSeer, BBAI is increasingly positioned as a specialized, “secure-first” alternative to larger peers like Palantir, specifically targeting the $24B defense and national security AI market.

C3.ai Inc. (AI): $8.72 USD, +3.01% (+$0.26 USD), Technology/Software-Application. Shares of the enterprise AI provider are seeing a modest relief bounce today as the company executes a major strategic reset. The uptick follows the announcement of a $135 million restructuring plan, which includes a 26% workforce reduction aimed at streamlining operations after a massive Q3 revenue miss. While the company faces a “SaaSpocalypse” on the commercial side—with subscription revenue plunging 46%—investors are finding a silver lining in its Federal and Defense business, where bookings recently surged 134%. By pivoting toward “Agentic AI” and securing high-stakes contracts with the U.S. Space Force, C3.ai is attempting to reinvent itself as a lean, defense-focused AI prime. Despite a 36% year-to-date decline and heavy insider selling by founder Thomas Siebel, the stock is attracting “dip buyers” who view its $621 million cash cushion and record-low valuation as a potential turnaround opportunity.

Super Micro Computer Inc. (SMCI): $21.59 USD, +5.16% (+$1.06 USD), Technology/Computer Hardware. Shares of the AI server leader are seeing a slight technical bounce today, March 24, 2026, following a catastrophic 33% plunge last week. The crash was triggered by the unsealing of a federal indictment—dubbed “Operation Gatekeeper”—alleging that three individuals associated with the company, including co-founder Wally Liaw, participated in a $2.5 billion scheme to smuggle high-end NVIDIA GPUs to China via dummy servers in Southeast Asia. While SMCI itself has not been named as a defendant and has placed the involved employees on leave, the news has shattered investor trust and reignited fears regarding the company’s internal controls. Despite a record $22B in 2025 revenue and a massive $13B Blackwell Ultra order book, SMCI is now navigating a “survival and remediation” phase. Analysts have slashed price targets to the $22–$40 range, citing concerns that legal scrutiny may cause NVIDIA to prioritize “cleaner” partners like Dell and HPE. Today’s 5% uptick reflects opportunistic “bottom fishing” as the stock trades at a distressed 5x forward earnings, but the looms of a potential S&P 500 removal and ongoing DOJ investigations keep the long-term outlook highly speculative.

Broadcom Inc. (AVGO): $322.51 USD, +4.08% (+$12.65 USD), Technology/Semiconductors. Shares of the chip giant surged today as the “AI optical” trade gains momentum following a sector-wide relief rally. The move is anchored by Broadcom’s record Q1 results, which saw AI revenue skyrocket 106% to $8.4 billion, fueled by massive demand for custom AI accelerators (ASICs) from hyperscalers like Google and Meta. While the integration of VMware remains a focal point, investors are cheering management’s 2026 guidance, which now projects AI-related sales to exceed $12.1 billion for the full year. With a dominant position in high-end Ethernet switching and a $10 billion share buyback program in full swing, Broadcom is increasingly viewed as the “backbone” of the global AI infrastructure build-out.

goeasy Ltd. (GSY): $38.82 CAD, +7.98% (+$2.87 CAD), Financial Services/Consumer Lending. Shares of the Canadian lender are rebounding today following a brutal 70% year-to-date selloff. This 8% “relief rally” comes just ahead of tomorrow’s Q4 earnings release, as contrarian investors bet on a bottom following the company’s recent dividend suspension and a massive $230M charge related to LendCare loan losses. While management has withdrawn its three-year guidance, the appointment of a permanent CFO and a 134% surge in federal-related bookings are providing a much-needed stability signal. Trading at a steep discount to its historical valuation, GSY remains a high-stakes “turnaround” play for 2026.

Rivian Automotive Inc. (RIVN): $15.77 USD, +5.77% (+$0.86 USD), Consumer Cyclical/Auto Manufacturers. Shares are rallying today as investors digest a massive strategic pivot that shifts Rivian from a “niche adventure brand” to a high-volume AI and software platform. The center of this pivot is the $1.25 billion Uber partnership, which transitions Rivian into the autonomous ride-hailing space with plans to deploy 50,000 R2-based “robotaxis” by 2031.

📉 Top Losers – WebKarobar Daily Market Movers

Regencell Bioscience Holdings Ltd (RGC): $25.22 USD, -7.87% (-$2.16 USD), Healthcare/Biotechnology. Shares of the Hong Kong-based TCM (Traditional Chinese Medicine) developer are retreating today, paring back gains from a highly volatile March. The slide follows a series of SEC Form 3 filings and a 38-for-1 stock split that has left the stock’s $12.4B market cap heavily disconnected from its “zero revenue” fundamentals. Despite reporting a 37% symptom improvement in its second efficacy trial for ADHD and ASD, investor sentiment is being tested by an ongoing DOJ investigation into potential securities law violations and “going concern” warnings from its auditors. While the recent extension of insider lock-up agreements through April 2027 provides a temporary supply floor, the stock remains a high-risk “meme-proxy” in the biotech space, frequently prone to double-digit swings as it approaches critical technical support at the $19.67 level.

Liberty Energy Inc. (LBRT): $29.11 USD, -7.44% (-$2.34 USD), Energy/Oil & Gas Services. Shares are retreating from recent 52-week highs as a sharp drop in crude oil prices—fueled by easing Middle East tensions—pressures the entire sector. The decline is amplified by management’s cautious Q1 guidance, which cites “pricing headwinds” and winter weather disruptions that are expected to weigh on near-term EBITDA. Despite today’s pullback, the narrative remains centered on Liberty’s aggressive $1 billion pivot into “Physical AI.” The company is currently deploying its 1-gigawatt partnership with Vantage Data Centers to provide on-site power for AI workloads, aiming to become a diversified energy-tech leader by 2027. Trading at a high P/E of 32x, the stock is seeing a “valuation reset” as investors weigh these long-term AI-power prospects against the immediate softening of the North American frac market.

SolarEdge Technologies Inc. (SEDG): $46.73 USD, -9.60% (-$4.96 USD), Technology/Solar. Shares of the solar inverter leader are retreating today in a sharp “valuation reset” after hitting a 52-week high of $53.24 last Friday. The sell-off is largely driven by institutional profit-taking following a massive 38% rally last week, which was sparked by a major Jefferies upgrade and the successful launch of the Nexis residential system in Germany. While the market is cheering SolarEdge’s 71% year-over-year revenue growth and its regaining of top U.S. market share, today’s drop reflects lingering anxiety over the company’s -34% net margins and the scheduled step-down of U.S. residential tax incentives. Despite the pivot toward AI data center power solutions and a “turnaround” narrative for late 2026, SEDG remains highly sensitive to interest rate volatility, with analysts maintaining a cautious “Hold” consensus as the company works toward its first profitable quarter in nearly two years.

Northrop Grumman Corp (NOC): $680.00 USD, -3.81% (-$26.95 USD), Aerospace & Defense. Shares are pulling back today as a broader cooling of Middle East tensions saps the “geopolitical risk premium” from the defense sector. The sell-off is a sharp reversal from last week’s highs, with investors locking in profits despite the company securing a massive $4.5 billion contract to accelerate B-21 Raider production by 25%. While the Air Force is now eyeing a larger fleet of 145 stealth bombers, the market is weighing the near-term costs of Northrop’s $2B–$3B infrastructure investment required to meet these faster delivery timelines. Additionally, while the Sentinel ICBM program has shown technical progress with successful motor tests, its ongoing restructure and the “Milestone B” delay until late 2026 continue to act as a valuation overhang.

Lockheed Martin Corp (LMT): $616.25 USD, -1.78% (-$11.18 USD), Aerospace & Defense. Shares are pulling back from recent record highs as investors lock in profits following a cooling of geopolitical tensions. The move is exacerbated by a new report from Breaking Defense suggesting that over 100 F-35s may be delivered without radars due to production bottlenecks with the APG-85 sensor. While the Pentagon remains committed to the program with a massive $24 billion contract for Lots 18-19, the “non-combat-ready” status of these initial units introduces near-term delivery and retrofit risks. Additionally, the market is monitoring a fresh $4.25 billion IP lawsuit from SDR Group regarding hybrid-airship technology, which has added a layer of legal uncertainty ahead of the company’s $3.45 per share dividend payment this Friday.

Daily Market Movers: US & Canada Top Movers (March 19, 2026)

AXT Inc. (AXTI): $58.09 USD, +19.13% (+$9.33 USD), Technology/Semiconductors. Shares of the specialty substrate manufacturer hit new all-time highs as the “AI optical” trade intensifies. The surge is primarily fueled by news that the company has begun receiving critical export permits from China for its indium phosphide (InP) substrates, which are essential for high-speed AI data center connectivity. Despite historical trade frictions and high insider selling by the CEO, investor confidence is peaking following management’s plan to double manufacturing capacity in the second half of 2026 to meet surging demand from hyperscalers like Google and Amazon. This “foundry momentum”—coupled with a wave of price target hikes from firms like Wedbush and Northland—has turned AXTI into a top-tier momentum play for the AI infrastructure super-cycle.

Lucid Group Inc. (LCID): $10.30 USD, +3.52% (+$0.35 USD), Consumer Cyclical/Auto Manufacturers. Shares of the luxury EV maker climbed as the company successfully navigated a high-stakes March 2026 Investor Day and subsequent appearances at the Bank of America Global Automotive Summit. The rally is driven by the unveiling of a new Midsize platform, featuring two SUVs (codenamed Cosmos and Earth) set to start below $50,000, alongside a dedicated robotaxi concept named Lunar. Investor sentiment was further bolstered by a massive $1.36 billion stake revealed by Tudor Investment Corp and a rare “Buy” rating from Citi with a $17 price target. While the company continues to face a significant cash burn—reporting a $1.06 billion operating loss in Q4 2025—the market is focusing on a 68% year-over-year revenue jump and a “conservative” 2026 production target of 25,000–27,000 vehicles. With a liquidity bridge of $4.6 billion extending into 2027 and a scaling partnership with Uber, LCID is showing signs of a technical floor as it attempts to break a long-term downtrend.

dLocal Ltd (DLO): $12.53 USD, +9.43% (+$1.08 USD), Financial Services/Payments. Shares of the Uruguay-based payments platform surged after the company delivered a massive Q4 2025 revenue beat and authorized a major capital return program. Revenue for the quarter skyrocketed 65% year-over-year to $337.9 million, crushing the $294 million consensus, while Total Payment Volume (TPV) hit a record $13.1 billion. The rally is being supercharged by a new $300 million share buyback program—representing roughly 9% of its market cap—and a $57 million cash dividend. Despite some margin compression (gross margin fell to 34% due to scaling with larger merchants), management’s aggressive 2026 guidance projects TPV growth of 50%–60%. With net income jumping 87% to $55.6 million and a “clean” balance sheet showing over $719 million in cash, investors are re-rating DLO as a highly profitable, cash-generative leader in emerging market fintech.

Tower Semiconductor Ltd. (TSEM): $166.08 USD, +16.99% (+$24.12 USD), Technology/Semiconductors. Shares of the Israeli-based specialty foundry hit a fresh all-time high following back-to-back announcements that have positioned the company as a “hidden” leader in AI infrastructure. The primary driver is a new strategic partnership with Oriole Networks to commercialize nanosecond optical circuit switching—a technology designed to solve the “AI latency wall” by replacing traditional electrical switches with ultra-fast light-based networking. This follows the release of Tower’s Gen3 BCD power management platform, which specifically targets the massive energy demands (the “Power Wall”) of next-gen AI data centers. With revenue from its Silicon Photonics division already more than doubling in 2025 and a massive $920 million CapEx plan to quintuple capacity by late 2026, institutional investors are re-rating TSEM as a critical backbone for 1.6T optical modules and AI networking fabrics.

AEye Inc. (LIDR): $2.59 USD, +38.50% (+$0.72 USD), Technology/Electronic Equipment. Shares of the lidar developer surged as the company reported a “commercial inflection” during its Q4 2025 earnings call this week. The rally is primarily driven by AEye joining the NVIDIA Halos AI Systems Inspection Lab, a move that deeply integrates its Apollo and Stratos sensors into the NVIDIA DRIVE autonomous vehicle ecosystem. Management reported a 33% increase in active, revenue-generating customers and highlighted a $30 million revenue opportunity with a global transportation OEM. With a strengthened balance sheet showing $86.5 million in cash—extending the company’s operational runway into 2028—investors are re-rating the stock as a leader in “Physical AI” and long-range perception. This combination of an EPS beat, a strategic NVIDIA partnership, and a capital-light manufacturing model has triggered a massive momentum break above the $2.00 psychological level.

Serina Therapeutics Inc. (SER): $2.48 USD, +93.75% (+$1.20 USD), Healthcare/Biotech. Shares nearly doubled as the company secured a $15 million initial tranche of a larger $63.3 million strategic financing deal. Led by Dr. Greg Bailey—known for backing multi-billion dollar exits like Biohaven—the placement was priced at $2.25 per share, representing a massive 68% premium to the prior close. This critical capital injection extends Serina’s runway into late 2027, fast-tracks clinical trials for its Parkinson’s candidate (SER-252), and effectively addresses previous NYSE American delisting risks. The combination of high-profile “smart money” backing and a low-float structure has triggered a violent upward re-rating and a potential short squeeze.

Duluth Holdings Inc. (DLTH): $3.14 USD, +44.70% (+$0.97 USD), Consumer Cyclical/Apparel. Shares of the workwear retailer skyrocketed following a massive Q4 2026 earnings beat that saw adjusted EPS of $0.23, crushing the analyst estimate of $0.09 by over 155%. While net sales saw a 10.5% year-over-year decline to $215.9 million, the market focused on a “miracle” 890-basis-point expansion in gross margin (to 53.0%) driven by strategic pricing and lower product costs. Management’s aggressive inventory reduction (down 21%) and positive $16.6 million free cash flow for the year signal a successful pivot toward profitability over raw growth. Despite the sales headwinds, this “bottom line” turnaround—coupled with bullish insider buying from 13 different executives over the past year—has fueled a violent relief rally as the stock breaks back above its 200-day moving average.

Wetour Robotics Ltd (WETO): $0.69 USD, +64.64% (+$0.27 USD), Industrials/Transportation. Shares of the recently rebranded TravelTech firm skyrocketed following its official pivot into Physical AI and the establishment of a new global headquarters in Austin, Texas. Formerly known as Webus International, the company is capturing investor interest with the unveiling of Orchestra, an AI operating system designed to offload heavy computing from wearable robotics (like smart glasses and gesture-control bands) to a portable hub. Despite a history of heavy cash burn and a 23% year-over-year revenue decline, the stock’s massive rally is being fueled by a speculative “identity shift” and a recent $5.16 million private placement. While the company still faces a “weak” financial health rating, the aggressive move into the U.S. robotics talent pool—combined with a low-float structure—has turned WETO into a high-volatility favorite for traders betting on the convergence of AI and wearable hardware.

Vermilion Energy Inc. (VET): $19.83 CAD, +14.36% (+$2.49 CAD), Energy/Oil & Gas. Shares of the Calgary-based producer hit a new 52-week high on the TSX following a major “bottom-line” turnaround in its Q4 2026 report. While the company posted a net loss due to non-cash impairments, the market focused on record production of 119,919 boe/d and a massive 36% increase in 2P reserves. The rally is being supercharged by a 4% dividend hike to $0.135 CAD and a $700 million debt reduction since early 2025, signaling a permanent shift toward high-margin shareholder returns. With 85% of its 2026 capital now flowing into premium European gas assets, Vermilion is uniquely positioned to capture international price premiums that are triple the North American benchmark. This aggressive deleveraging and production beat have triggered a violent breakout, pulling VET into “overbought” territory as it tests the $20.00 psychological resistance.

Tilly’s Inc. (TLYS): $3.67 USD, +2.80% (+$0.10 USD), Consumer Cyclical/Apparel. Shares of the youth-culture retailer continued their March climb, building on a massive 47% single-day surge earlier this month following a “transformational” Q4 2025 earnings report. The company reported its first profitable fourth quarter and full-year positive comparable sales since 2021, posting an EPS of $0.10 which crushed the consensus estimate of a $0.32 loss. The rally is sustained by management’s “unprecedented” start to fiscal 2026, highlighted by a 20.1% jump in February comparable sales and guidance for Q1 revenue to reach up to $125 million. With gross margins expanding by 720 basis points due to disciplined inventory management and the promotion of Michael J. Cingolani to Chief Merchandising Officer, investors are betting on a permanent turnaround. This momentum—bolstered by a pivot from store closures to planned new openings in 2026—has turned TLYS into one of the top retail recovery plays of the year.

Lightwave Logic Inc. (LWLG): $7.04 USD, +5.55% (+$0.37 USD), Technology/Semiconductors. Shares of the electro-optic polymer developer climbed as the company successfully integrated its high-speed modulator platform into the GlobalFoundries (GF) silicon photonics ecosystem. This follows a blockbuster development agreement with Tower Semiconductor (TSEM) earlier this month to enable 200G and 400G-per-lane architectures for AI data centers. The market is increasingly viewing LWLG’s Perkinamine® polymers as a vital solution to the “AI Power Wall,” as they allow for faster data transmission with significantly lower voltage than traditional lithium niobate. With a strengthened balance sheet following a $35 million public offering in December 2025 and a new Fortune Global 500 customer advancing to Stage 3 prototype development, investor focus has shifted from “science project” to “commercial scale-up.” While the company remains pre-revenue, these consecutive foundry wins and the appointment of Nokia veteran Dr. Aref Chowdhury as CTO have fueled a massive technical breakout toward 52-week highs.

Rocket Lab USA, Inc. (RKLB): $71.93 USD, +3.53% (+$2.45 USD), Industrials/Aerospace & Defense. Shares of the Long Beach-based aerospace powerhouse gained on Thursday following the announcement of a $190 million contract for 20 hypersonic test flights. This deal, the largest single launch agreement in the company’s history, utilizes the HASTE (Hypersonic Accelerator Suborbital Test Electron) vehicle for the Department of War’s MACH-TB 2.0 program. The contract has pushed Rocket Lab’s total backlog above $2 billion and significantly improved revenue visibility through 2029. While the stock faced brief volatility earlier this week due to a $1 billion equity distribution agreement (raising dilution concerns), the market has pivoted back to the growth narrative. Investors are now focused on the “Year of Neutron,” with the medium-lift, reusable rocket’s maiden flight scheduled for Q4 2026. With 28 new launches already sold in Q1 2026—nearly matching the entire previous year’s volume—Rocket Lab is increasingly being valued as a primary “defense prime” rather than a speculative startup.

📉 Top Losers – WebKarobar Daily Market Movers

Tesla Inc. (TSLA): $380.30 USD, -3.18% (-$12.48 USD), Consumer Cyclical/Auto Manufacturers. Shares of the EV leader slid on Thursday as the company faces a “dual-threat” of regulatory and macro headwinds. The primary catalyst is an expanded federal investigation into Tesla’s Full Self-Driving (FSD) system, with U.S. regulators intensifying their analysis of how the software handles real-world crashes, raising the specter of a massive recall. This regulatory pressure is colliding with a broader market sell-off triggered by spiking oil prices ($119 Brent) and geopolitical instability in the Middle East, which has dampened appetite for high-valuation growth stocks. While long-term bulls point to the newly launched Terafab semiconductor project and a potential FSD approval in the Netherlands as future catalysts, the immediate focus remains on a “weak” 2025 financial performance and a 47% drop in annual EPS. With the stock down 7% over the last month, TSLA is currently testing critical support levels as it trades roughly 158% above its estimated fair value.

Hycroft Mining Holding Corporation (HYMC): $31.76 USD, -12.36% (-$4.48 USD), Basic Materials/Gold & Silver Mining. Shares of the Nevada-based miner retreated on Thursday as investors took profits following a massive year-to-date rally and a recent 150-meter extension of high-grade silver at its Brimstone system. While the company recently reported a 55% increase in measured and indicated resources—now totaling 16.4 million ounces of gold and 562.6 million ounces of silver—the stock faced downward pressure after management confirmed that its much-anticipated Preliminary Economic Assessment (PEA) would be delayed beyond Q1 2026 to incorporate the new, larger resource scale. Despite a debt-free balance sheet with $194.1 million in cash and continued “ultra-high-grade” drill hits (peaking at 21,833 g/t silver), the delay in the project’s economic roadmap has triggered a short-term “sell the news” reaction. This volatility is further amplified by a broader cooling in precious metals as the market awaits the next Federal Reserve minutes.

NVIDIA Corp. (NVDA): $178.56 USD, -1.02% (-$1.84 USD), Technology/Semiconductors. Shares of the AI bellwether softened on Thursday as the broader tech sector grappled with “inflationary whiplash” from surging energy costs. Despite the minor pullback, NVIDIA remains the dominant force in AI infrastructure, recently unveiling its Blackwell-based B200 NVL72 systems which offer up to 30x the performance for LLM inference compared to the H100. The current consolidation is being viewed by analysts as a “healthy breather” following a massive 2026 run-up, as the company prepares to ship its first sovereign AI clusters to a $10 billion project in Saudi Arabia. While the stock is trading at a premium valuation and faces potential export headwind concerns due to Middle East instability, its 76% gross margins and a projected $120 billion revenue year continue to provide a solid fundamental floor. This 1% dip reflects a minor “risk-off” rotation rather than a shift in the AI narrative, as the stock holds firm above its 50-day moving average.

Inseego Corp. (INSG): $12.08 USD, -4.28% (-$0.54 USD), Technology/Communication Equipment. Shares of the 5G and IoT solutions provider pulled back on Thursday as investors balanced a strong Q4 2025 earnings beat against a conservative “transition” outlook for early 2026. While the company recently reported an adjusted EPS of $0.12 (crushing the $0.03 estimate) and secured key Fixed Wireless Access (FWA) wins with all three major U.S. Tier-1 carriers, the stock faced pressure due to Q1 2026 revenue guidance of $33M–$36M, which reflects a seasonal step-down from the $48.4M posted in Q4. Despite the dip, the long-term narrative remains focused on a “clean” capital structure following the 100% elimination of preferred stock and a full-year 2026 revenue target of $190M. This 4% retracement is being viewed by technical analysts as a test of the $11.98 support level following a recent multi-week rally driven by the Verizon and AT&T partnership announcements.

Micron Technology Inc. (MU): $444.27 USD, -3.78% (-$17.46 USD), Technology/Semiconductors. Shares of the memory giant slipped on Thursday in a classic “sell the news” reaction, despite delivering what analysts called a “triple-triple” blowout earnings report. Micron nearly tripled its year-over-year revenue to $23.9 billion and posted a staggering 682% jump in EPS to $12.20, crushing the Wall Street consensus of $8.65. The decline is attributed to investor jitters over a massive $25 billion CapEx plan for 2026 and fears that gross margins—which hit a record 74.4%—may be nearing a cyclical peak. However, the fundamental narrative remains elite: Micron has officially begun high-volume production of HBM4 for NVIDIA’s next-gen “Vera Rubin” platform and confirmed its entire 2026 HBM capacity is already sold out. While the heavy spending “spooked” short-term traders, the company’s 30% dividend hike and guidance for $33.5 billion in Q3 revenue signal that the AI-driven memory supercycle is accelerating rather than cooling.

Daily Market Movers: US & Canada Top Movers (March 18, 2026)

Regencell Bioscience Holdings Ltd (RGC): $26.38 USD, +14.85% (+$3.41 USD), Healthcare/Biotech. Shares surged nearly 15% on high volume following SEC disclosures of new insider ownership by the COO, CBO, and Financial Controller. This internal buying—combined with a lock-up extension through 2027—has signaled strong management confidence despite a lack of commercial revenue. The move was likely amplified by a short squeeze and the stock’s low-float structure, making it a “high-octane” favorite for speculative traders.

Andersen Group Inc (ANDG): $28.27 USD, +13.58% (+$3.38 USD), Financial Services. Shares surged over 13% after a UBS price target hike followed the company’s first post-IPO earnings report. Despite a GAAP loss from one-time IPO costs, revenue climbed 19.6% to $170.3M, beating forecasts. Investors were cheered by strong 2026 revenue guidance ($955M–$970M) and the firm’s aggressive push into AI-enhanced tax and valuation platforms, signaling a transition into a high-growth phase for the “Big Four” alternative.

Heartflow Inc (HTFL): $25.47 USD, +13.10% (+$2.95 USD), Med-Tech. Shares jumped over 13% as the company’s AI-driven FFRCT Analysis sees rapid clinical adoption. By creating 3D coronary models to detect blockages non-invasively, Heartflow has reduced unnecessary angiograms by 60%, leading to expanded insurance coverage. Investors are increasingly bullish on HTFL’s high-margin SaaS model as hospitals integrate these AI diagnostics into standard cardiac care.

Kingsoft Cloud Holdings Ltd (KC): $14.78 USD, +12.65% (+$1.66 USD), Technology/Cloud. Shares gapped up 12% following SEC filings revealing major insider buying by the Acting CEO and top executives. This “insider signal” comes just ahead of the March 25 earnings report, where investors expect a strategic pivot toward AI infrastructure to offset margin pressures. With analysts projecting 23% revenue growth driven by “Intelligent Cloud” demand, today’s rally suggests tactical positioning and a short cover by traders betting on a positive surprise.

MDA Space Ltd (MDA): $46.16 CAD, +5.80% (+$2.53 CAD), Aerospace & Defense. The stock climbed nearly 6% following a $32M contract from Canada’s Defence Investment Agency to build three deep-space observatories. This win capitalizes on the momentum of MDA’s successful $300M NYSE debut (ticker: MDA) on March 16. With a record $4.0B backlog and 51% revenue growth in 2025, the company is aggressively scaling its satellite and surveillance platforms. This rally reinforces MDA’s role as a “high-octane” industrial leader, driven by surging global demand for space-based defense and infrastructure.

Suncor Energy Inc (SU): $85.13 CAD, +1.21% (+$1.02 CAD), Energy. Suncor shares edged higher ahead of its March 31 Investor Day, riding the momentum of a record-breaking 2025. Having hit its $8B debt target early, the company is now returning 100% of excess cash flow to shareholders through buybacks and dividends. With production hitting an all-time high of 909,000 bpd and a dividend payment due March 25, Suncor has successfully transitioned into a high-efficiency “cash cow” for 2026.

Occidental Petroleum Corp (OXY): $58.38 USD, +1.13% (+$0.65 USD), Energy. The stock edged higher on Thursday, continuing its March rally as geopolitical tensions in the Middle East drive Brent crude toward the $100 mark. OXY’s “high-octane” momentum is fueled by a massive deleveraging phase, including a $9.7 billion divestiture of OxyChem to Berkshire Hathaway and recent $1.2 billion debt tender offers to slash high-interest obligations. With a 29% stake from Berkshire Hathaway serving as a structural floor and the Stratos Direct Air Capture (DAC) project nearing its mid-2026 launch, investors are rewarding OXY’s shift into a high-margin, carbon-managed cash machine.

Intel Corp (INTC): $45.03 USD, +2.20% (+$0.97 USD), Semiconductors. Intel gained over 2% as it enters high-volume manufacturing for its 18A process node, a critical milestone in reclaiming transistor leadership from TSMC. The rally is supported by the finalization of $7.86 billion in CHIPS Act funding and a strategic $8.9 billion U.S. government equity investment. With anchor foundry wins from Microsoft and AWS, plus a deepening AI partnership with NVIDIA, investors are betting on Intel’s “Foundry First” turnaround to establish a dominant domestic AI silicon supply chain by 2026.

📉 Top Losers – WebKarobar Daily Market Movers

Amprius Technologies Inc (AMPX): $18.90 USD, -2.48% (-$0.48 USD), Battery Tech. The stock pulled back from a fresh 52-week high of $19.76 as investors locked in gains following a massive 140% annual rally. Sentiment was weighed down by a significant wave of insider selling, including over $10 million in shares offloaded by directors Steven Chu and Wen Hsuan Hsieh in mid-March. While the company recently posted its first positive adjusted EBITDA quarter and raised its 2026 revenue guidance to $125M+, it remains GAAP unprofitable with a high cash burn. Additionally, a recent $120M shelf registration has raised concerns about potential share dilution, tempering the excitement from its growing drone and defense contract wins.

Meiwu Technology Co Ltd (WNW): $0.20 USD, -53.54% (-$0.23 USD), Consumer Cyclical. The stock plummeted over 53% on Thursday, following a highly dilutive $14 million registered direct offering. Meiwu sold 7 million shares and 7 million warrants at $2.00 each—a significant premium to the trading price at the time of the announcement—but the deal includes an unusual “zero exercise price” cashless option. This feature could potentially flood the market with up to 84 million new shares, causing extreme dilution for existing holders. The crash effectively wiped out the massive 625% gains seen earlier in the week when the company teased a strategic AI skincare initiative and a plan to invest 50% of offering proceeds into Bitcoin.

China Recycling Energy Corp (CREG): $0.59 USD, -50.02% (-$0.59 USD), Industrials. The stock collapsed 50% on Thursday, hitting a fresh 52-week low of $0.56 following a massive intraday sell-off. The crash was triggered by a highly dilutive $10M–$11.5M public offering of common stock and warrants aimed at raising working capital. This aggressive move overshadowed the company’s recent strategic pivots into “Green Energy NFTs” and Metaverse-based power projects. With a history of reverse stock splits to maintain Nasdaq compliance, investors reacted sharply to the threat of further share devaluation despite the company’s current liquidity position.

Amazon.com Inc. (AMZN): $209.87 USD, -2.48% (-$5.33 USD), Consumer Cyclical/Technology. The stock faced a pullback as investors weighed the company’s massive $200 billion capital expenditure plan for 2026—the highest among the “Magnificent Seven.” While AWS revenue growth has accelerated to 24% and CEO Andy Jassy recently forecasted cloud revenue could hit $600 billion by 2036 due to AI, the aggressive spending on data centers and custom Trainium chips has caused a sharp year-over-year drop in free cash flow. Additionally, sentiment was dampened by a historic $2.5 billion FTC settlement regarding Prime enrollment practices and a recent $70 million antitrust fine in Germany.

Texxon Holding Ltd (NPT): $8.05 USD, -48.89% (-$7.70 USD), Industrials. The stock plummeted nearly 50% on Thursday, triggering a volatility trading pause (LULD) as it hit a fresh low following a period of extreme price swings. The crash comes just as the company filed SEC Form 3s for its new CFO and Director, signaling a leadership transition ahead of its highly anticipated March 24 earnings report. While Texxon recently reached milestones for its 600,000-ton polystyrene project in Henan, the sudden sell-off suggests investor anxiety over its shift from a pure supply-chain trading model to a capital-intensive manufacturing “cash cow” strategy.

Daily Market Movers: US & Canada Top Movers (March 17, 2026)

Uber Technologies Inc. (UBER): $77.80 USD, +4.21% (+$3.14 USD), Industrials/Technology. The stock climbed as the company announced a major expansion of its autonomous vehicle (AV) strategy, including a new global partnership with NVIDIA to deploy Level 4 robotaxis using the DRIVE Hyperion platform. Sentiment was further bolstered by a deal with Amazon’s Zoox to launch autonomous rides in Las Vegas by summer 2026. These moves signal Uber’s shift toward an “asset-right” model, leveraging third-party hardware to scale AI-driven transport without heavy capital expenditure. The gain reflects investor optimism that Uber is successfully positioning itself as the central hub for the future of autonomous mobility.

Telesat Corp (TSAT): $42.34 USD, +19.27% (+$6.84 USD), Technology. The stock skyrocketed to a new 52-week high following the company’s Q4 2025 earnings report and a major strategic pivot for its Lightspeed low-earth orbit (LEO) constellation. Despite a wider-than-expected net loss, investors rallied around the announcement that Telesat is adding 500 MHz of military Ka-band spectrum to its first 156 satellites to capture surging global defense demand. Management also confirmed that the Lightspeed project is fully funded through its global service commencement, overshadowing a slight three-month delay in the full launch timeline. The massive gain reflects a market pivot toward Telesat’s high-margin government and sovereignty contracts as a key differentiator in the competitive satellite broadband sector.

Elbit Systems Ltd (ESLT): $1,014.33 USD, +15.99% (+$139.83 USD), Industrials/Defense. The stock surged to an all-time high after the company reported blockbuster Q4 2025 results, surpassing the $2 billion quarterly revenue milestone for the first time. Adjusted EPS of $3.56 crushed analyst estimates of $3.23, driven by a 16% year-over-year revenue climb and significant margin expansion. Investors were particularly focused on the record-breaking order backlog, which reached $28.1 billion—providing nearly 3.5 years of revenue visibility. The rally underscores strong global demand for Elbit’s electronic warfare and AI-enhanced defense platforms, especially as regional tensions in the Middle East and Europe continue to drive heightened defense spending.

Lemonade Inc. (LMND): $66.87 USD, +15.81% (+$9.13 USD), Financials/Technology. The stock soared in Tuesday’s session following a major upgrade from Morgan Stanley, which raised the insurer from Equal-weight to Overweight and hiked its price target to $85. Analysts cited Lemonade’s “first-mover advantage” in the autonomous vehicle space, specifically highlighting its strategic partnership with Tesla to offer deeply discounted insurance for drivers using Full Self-Driving (FSD) technology. The rally was further supported by a strong Q4 earnings beat and 2026 guidance that surpassed Wall Street estimates, signaling a faster-than-expected path to profitability. The double-digit gain reflects growing market confidence in Lemonade’s ability to leverage AI and real-time driving data to disrupt traditional auto insurance paradigms.

Solaris Energy Infrastructure Inc. (SEI): $63.19 USD, +10.88% (+$6.20 USD), Energy/Utilities. The stock hit an all-time high in Tuesday’s session following the announcement that Solaris has closed two major transactions to add 900 MW of natural gas-fueled turbine capacity between 2026 and 2029. This expansion includes the acquisition of Genco Power Solutions and the purchase of 30 specialized turbine delivery slots, positioning the company to meet surging “behind-the-meter” power demand from AI data centers and industrial hyperscalers. Sentiment was further electrified by Barclays, which raised its price target to $74, citing high confidence in the company’s ability to secure a third major hyperscale contract. The double-digit gain reflects a massive investor pivot toward infrastructure providers capable of bypassing grid bottlenecks to deliver immediate power solutions for the AI buildout.

Western Digital Corp. (WDC): $313.81 USD, +9.64% (+$27.60 USD), Technology. The stock surged to an all-time high after reports surfaced that the company has effectively sold out its entire HDD manufacturing capacity for the remainder of 2026. This “capacity lock-in” is driven by a massive supply deficit in the storage market as hyperscale cloud providers race to build out the “data lakes” required for multimodal AI training. Investors were further encouraged by management’s “Road to $20 EPS” target, supported by multi-year supply agreements that insulate the company from traditional hardware cyclicality. The gains reflect a fundamental re-rating of Western Digital from a commodity vendor to a mission-critical utility for the global AI infrastructure boom.

Micron Technology Inc. (MU): $461.69 USD, +4.50% (+$19.89 USD), Technology. The stock climbed in Tuesday’s session as investors positioned themselves ahead of the company’s highly anticipated quarterly earnings report scheduled for tomorrow. Optimism is surging around Micron’s High Bandwidth Memory (HBM3E) production, which is a critical component for NVIDIA’s next-generation AI GPUs. Analysts at Citi and Rosenblatt recently reiterated “Buy” ratings, citing a “structural shift” in memory demand as AI servers require significantly higher DRAM content than traditional data centers. The gain reflects a “front-running” sentiment as the market bets on a significant beat-and-raise guided by the tightening global supply of advanced memory chips.

Palantir Technologies Inc. (PLTR): $155.08 USD, +1.55% (+$2.36 USD), Technology. The stock edged higher in Tuesday’s session as the company announced a significant expansion of its partnership with the U.S. Army for the “Titan” ground station program, integrating new tactical AI capabilities at the edge. Investor sentiment remains buoyed by the rapid adoption of Palantir’s AIP (Artificial Intelligence Platform), which saw a 42% surge in commercial bootcamps over the last quarter. Despite the modest percentage gain compared to some high-flying peers, the stock continues to consolidate near all-time highs as it shifts from a speculative growth play to a foundational enterprise software utility. The gains reflect a steady “accumulation” phase as the market anticipates further S&P 500 weight increases and large-scale government contract renewals through 2027.

Suncor Energy Inc. (SU): $84.11 CAD, +1.42% (+$1.18 CAD), Energy. Canada’s integrated energy giant edged higher on Tuesday as WTI crude prices climbed toward $96 per barrel amid escalating Middle East supply risks. The stock’s gains were bolstered by the company’s official announcement of its 2026 Investor Day, where management is expected to unveil a multi-year “Free Cash Flow” strategy focused on debt reduction and increased shareholder buybacks. While the broader TSX faced headwinds from softening gold prices, Suncor outperformed its peers as investors rewarded its “oil sands-to-gas station” integrated model, which captures higher margins during periods of volatile global benchmarks. The move reflects a “defensive growth” sentiment as Suncor optimizes its asset base for a high-price energy environment through 2027.

WELL Health Technologies Corp. (WELL): $4.27 CAD, +2.40% (+$0.10 CAD), Healthcare/Technology. Canada’s largest owner-operator of outpatient medical clinics saw a steady gain in Tuesday’s session as the company announced a milestone integration of its “WELL AI Voice” assistant across its primary care network. Investor sentiment was bolstered by a record-breaking Q4 2025 revenue report, which highlighted a 22% organic growth rate driven by high-margin digital health services and a successful expansion into the U.S. patient-services market. The uptick reflects growing market confidence in WELL’s ability to leverage AI-driven administrative automation to combat physician burnout while maintaining double-digit EBITDA growth. Despite broader volatility in the Canadian tech sector, the stock continues to attract “growth-at-a-reasonable-price” (GARP) investors looking for a resilient play in the evolving hybrid-care landscape.

Eli Lilly and Co. (LLY): $930.35 USD, -5.94% (-$58.77 USD), Healthcare. The stock plummeted in Tuesday’s session as it became the target of a rare and aggressive “double-whammy” of bearish sentiment. HSBC analyst Rajesh Kumar spearheaded the decline by slashing the rating from “Hold” to “Reduce” (Sell) and dropping the price target to $850, arguing the market’s 2032 obesity drug forecasts are overinflated by as much as $70B. Sentiment was further soured by “highly competitive” trial data from Structure Therapeutics, which showed its oral weight-loss pill achieving up to 16.3% weight loss—directly challenging Lilly’s upcoming oral drug, orforglipron. The sharp decline reflects a “reality check” for the healthcare giant, as investors weigh intensifying price competition and high valuation against a more skeptical outlook on long-term patient compliance and cash-pay sustainability.

Nebius Group N.V. (NBIS): $116.33 USD, -10.41% (-$13.52 USD), Technology. The stock pulled back sharply on Tuesday as the market digested a massive $3.75 billion convertible senior notes offering. While the capital is earmarked to fund a high-stakes $16B–$20B data center expansion roadmap for 2026, the announcement triggered immediate dilution fears and concerns over increased leverage. The decline also reflects significant profit-taking following a 15% surge in the previous session tied to a landmark $27 billion AI infrastructure deal with Meta. Despite Citi initiating coverage with a “Buy” rating and a $169 price target, analysts explicitly labeled the stock “High Risk,” noting its heavy reliance on a few hyperscale customers and its limited trading history. The day’s move highlights a volatile tug-of-war between Nebius’s explosive 479% revenue growth and the immense capital intensity required to scale its AI “factories.”

Aldeyra Therapeutics (ALDX): $1.24 USD, -70.69% (-$2.99 USD), Healthcare/Biotech. The stock suffered a catastrophic “strike three” sell-off on Tuesday after the FDA issued its third Complete Response Letter (CRL), rejecting the company’s New Drug Application for reproxalap (a dry eye disease treatment). In a scathing review, the FDA stated the application lacked “substantial evidence” of efficacy, citing inconsistent study results and questioning the “reliability and meaningfulness” of the drug’s positive findings. Crucially, the agency noted that the “totality of evidence” simply does not support that the drug actually works. While no safety or manufacturing issues were raised, the sheer bluntness of the rejection—marking the third failure for this specific drug in three years—has led to a collapse in investor confidence and a surge in legal scrutiny.

Daily Market Movers: US & Canada Top Movers (March 16, 2026)

NVIDIA Corp. (NVDA): $183.19 USD, +1.63% (+$2.94 USD), Technology. The stock edged higher as the company kicked off its GTC 2026 conference, where CEO Jensen Huang unveiled DLSS 5, a neural rendering breakthrough, and the NemoClaw platform for secure enterprise AI agents. Despite macro pressure from rising oil prices and geopolitical tensions in West Asia, investors are encouraged by Huang’s projection of a $1 trillion order backlog by 2027. The gains reflect a “buy the news” sentiment as NVIDIA expands its moat into agentic AI and next-gen inference infrastructure.

Shopify Inc. (SHOP): $173.21 CAD, +2.59% (+$4.38 CAD), Technology. The stock rose on the TSX as investors “recalibrated” expectations ahead of Federal Reserve and Bank of Canada meetings, with Shopify emerging as a top sector performer. Momentum is being driven by the massive “Winter ’26: Renaissance” update, which introduced over 150 AI-driven features, including “Sidekick Pulse” (a proactive AI coworker) and “Agentic Storefronts” that make products natively discoverable by AI agents like ChatGPT and Perplexity. With a new $2 billion share buyback program active and revenue recently beating estimates by 30%, the market is increasingly viewing Shopify not just as a store builder, but as the essential infrastructure for the emerging “agentic commerce” era.

Xenetic Biosciences Inc. (XBIO): $3.38 USD, +20.38% (+$0.57 USD), Healthcare. The stock surged on heavy volume following the company’s full-year 2025 financial report and a series of constructive updates regarding its DNase-based oncology platform. Investors are reacting positively to a 19% increase in royalty revenue from its Takeda partnership and the company’s steady progress toward Phase 1 clinical trials for XBIO-015. With a strengthened cash position of $7.9 million and expanding preclinical evidence that its technology effectively targets Neutrophil Extracellular Traps (NETs) to improve CAR-T and chemotherapy outcomes, the market is re-evaluating the micro-cap’s potential as it nears critical IND-enabling milestones for pancreatic and solid tumor treatments.

CytomX Therapeutics Inc. (CTMX): $6.75 USD, +44.23% (+$2.07 USD), Healthcare. The stock surged on heavy trading volume following a positive clinical update regarding its Probody® therapeutic platform and progress in its oncology pipeline. Investors are reacting to the company’s ability to maintain high-drug-concentration efficacy while reducing systemic toxicity, positioning CTMX as a high-potential player in the development of next-generation antibody-drug conjugates (ADCs) for hard-to-treat solid tumors.

Meiwu Technology Co Ltd (WNW): $2.15 USD, +19.44% (+$0.35 USD), Consumer Discretionary. The stock surged on heavy speculative volume following the launch of its “Strategic AI Insights Initiative,” aimed at enhancing functional skincare research and operational efficiency. The move also comes after a recent $30.2 million capital raise, with the company outlining plans to allocate a significant portion of proceeds toward a Bitcoin-focused treasury strategy. However, despite the combined AI and crypto narrative, the stock’s extreme intraday volatility — peaking near $13.52 — reflects classic low-float momentum dynamics. Overall, the price action highlights a high-risk trading environment, where speculative sentiment appears to outweigh near-term fundamental execution.

Distribution Solutions Group Inc. (DSGR): $26.07 USD, +35.01% (+$6.76 USD), Industrials. The stock climbed sharply as the company outperformed market expectations in its latest fiscal report, driven by robust organic growth across its Lawson Products and TestEquity divisions. Investors are bullish on DSGR’s strategic M&A integration and its expanding footprint in the high-demand maintenance, repair, and operations (MRO) sector, which is benefiting from a broader industrial resurgence.

National Storage Affiliates Trust (NSA): $40.23 USD, +30.03% (+$9.29 USD), Real Estate. The stock jumped on significant volume following a major institutional upgrade and rumors of a potential private equity buyout targeting the self-storage sector. Investors are piling in as the trust demonstrates resilient occupancy rates and strong pricing power, making it an attractive defensive play amid broader economic volatility and a shifting housing market.

Meta Platforms Inc. (META): $627.45 USD, +2.33% (+$14.27 USD), Technology. Shares gained momentum following exclusive reports that Meta is planning a massive restructuring, potentially cutting 20% or more of its workforce (approx. 16,000 jobs) to offset a staggering $135 billion AI capital expenditure forecast for 2026. Despite a reported delay of its next-gen frontier model, “Avocado,” until May, investors are cheering the aggressive “efficiency” play and the company’s landmark $27 billion deal with Nebius to secure AI cloud capacity. The market is increasingly viewing Meta as a premier “Agentic AI” incumbent, bolstered by its recent acquisition of the AI-agent social platform Moltbook and the ongoing rollout of the Llama 4 ecosystem.

Healwell AI Inc. (AIDX): $0.95 CAD, +7.95% (+$0.07 CAD), Healthcare. The stock rallied on the TSX as the company announced it has reached a milestone of 47 peer-reviewed publications, reinforcing the “scientific moat” for its DARWEN™ AI platform. Bullish sentiment is being driven by recent multi-million dollar contract wins in the U.S. and the Middle East, alongside anticipation for the Q4 and Full Year 2025 financial results scheduled for release this Thursday, March 19. Investors are increasingly viewing AIDX as a high-growth leader in preventative care and clinical decision support, with analysts maintaining aggressive price targets as the company integrates its AI capabilities across North American healthcare networks

Robinhood Markets Inc. (HOOD): $75.31 USD, +2.62% (+$1.92 USD), Financial Services. The stock climbed as investors reacted to February operating data showing a massive 68% year-over-year surge in platform assets to $314 billion and a 74% jump in crypto trading volumes. While broader markets faced pressure from rising oil prices, Robinhood’s aggressive expansion—including its new Platinum credit card, the launch of tokenized stocks in the EU, and the $1 billion milestone for its banking division—continues to fuel the “Financial Super App” narrative. Bullish sentiment is further supported by the company’s deepening integration of AI with its Cortex assistant and its entry into institutional-grade crypto through the Bitstamp acquisition.

Rivian Automotive Inc. (RIVN): $15.33 USD, +3.16% (+$0.47 USD), Consumer Cyclical. The stock pushed higher as the company officially opened pre-orders for its highly anticipated R3 and R3X compact crossovers, signaling a critical move into the mass-market EV segment. Investors are encouraged by Rivian’s updated production guidance at its Normal, Illinois plant, which suggests a significant improvement in gross margins per vehicle as the company transitions to its “Gen 2” architecture. Despite high interest rates impacting the luxury EV market, the brand’s cult-like following and the expansion of its Adventure Fast Network charging stations are keeping the “Tesla Alternative” narrative alive for long-term holders.

Nio Inc. (NIO): $6.03 USD, +2.90% (+$0.17 USD), Consumer Cyclical. The stock extended its post-earnings rally as investors digest the company’s first-ever quarterly net profit of $40.4 million (RMB 282.7 million) and a surge in vehicle margins to 18.1%. Market sentiment is being driven by a wave of analyst upgrades—including HSBC and Nomura shifting to “Buy”—following Nio’s guidance for nearly 100% year-over-year delivery growth in Q1 2026. Despite volatility in the broader Chinese EV sector, the successful scale-up of the premium ES8 and the 100-millionth milestone for its battery-swap network have convinced bulls that Nio’s high-capex infrastructure is finally translating into a sustainable, profitable business model.

Li Auto Inc. (LI): $18.24 USD, +5.25% (+$0.91 USD), Consumer Cyclical. The stock rallied as investors shifted focus toward the company’s aggressive 2026 recovery plan, despite a recent 35% year-over-year revenue drop in its Q4 report. Bullish sentiment is being driven by the upcoming Q2 launch of the next-gen L9 flagship and the strategic pivot toward “Project Nexus,” an internal humanoid robotics initiative. With a $101 billion RMB cash reserve, the market is betting on Li Auto’s ability to survive the “bloody” price war in China by transitioning from range-extender vehicles to a sophisticated “large battery + fast charging” ecosystem and embodied AI.

📉 Top Losers – WebKarobar Daily Market Movers

CrowdStrike Holdings Inc. (CRWD): $423.84 USD, -4.06% (-$17.94 USD), Technology. The stock pulled back as investors weighed a premium valuation against “AI de-risking” jitters and the impact of rising oil prices on enterprise IT spending. Despite a blockbuster Q4 report earlier this month—highlighted by a record $1.01 billion in net new Annual Recurring Revenue (ARR)—the market remains sensitive to competition from new AI-native security tools like Claude Code Security. However, the long-term “Agentic” narrative remains strong; NVIDIA just confirmed at GTC 2026 that CrowdStrike is a foundational partner for its new Agent Toolkit, integrating Charlotte AI to secure self-evolving enterprise agents. Traders are now looking to the Fal.Con Gov conference on March 18 for potential government contract catalysts that could reverse the dip.

SentinelOne Inc. (S): $14.29 USD, -1.58% (-$0.23 USD), Technology. The stock stabilized following a post-earnings slide after reaching a “landmark” milestone: surpassing $1 billion in annual revenue for the first time. While Q4 results were strong—beating EPS estimates ($0.07 vs. $0.06)—investors were spooked by cautious Q1 2027 profit guidance ($0.01–$0.02 vs. $0.05 consensus) and the upcoming transition to new CFO Sonalee Parekh on March 24. Despite the dip, long-term indicators remain robust: Purple AI attach rates reached a record 50% for new licenses, and the company achieved its first full year of positive free cash flow. Analysts remain divided, with several firms trimming price targets to the $14–$18 range due to decelerating growth and competition from AI-native tools like Claude Code Security.

Gartner Inc. (IT): $160.25 USD, -3.86% (-$6.43 USD), Technology. Shares slid as the research giant continues to grapple with “AI cannibalization” fears and a “much tougher selling environment.” While the company reported a modest EPS beat in its latest quarterly update, revenue growth slowed to just 2.2% as enterprise clients—navigating their own AI transitions—are “slowing and deferring everything possible.” Investors are particularly concerned by conservative 2026 guidance and reports that AI desktop agents, like Claude Code, are beginning to automate the high-level advisory and contract-review work that is Gartner’s “bread and butter.”

10x Genomics Inc. (TXG): $16.69 USD, -11.18% (-$2.10 USD), Healthcare. The stock plummeted after Ark Invest significantly trimmed its position, coupled with investor anxiety over “subdued” 2026 revenue guidance. Despite narrow losses in the recent Q4 report, the market is punishing TXG for a projected 0–4% growth rate in 2026 and ongoing weakness in capital equipment sales (instruments fell 36% last quarter). While the company is betting on its new Xenium spatial biology platform and AI partnerships like PharosAI to drive long-term demand, current high-risk technical signals and “double top” formations have triggered a wave of short-term selling.

CRISPR Therapeutics AG (CRSP): $48.42 USD, -0.68% (-$0.33 USD), Healthcare. The stock eased slightly on moderate volume as the company settled its upsized $550 million convertible senior notes offering. While the capital raise provides a massive cash runway for its “SyNTase” editing platform, the 1.125% coupon and potential future dilution have led to a short-term “consolidation phase.” Investors are looking past the recent Q4 earnings miss and focusing on the accelerating commercial rollout of CASGEVY, which saw patient initiations triple year-over-year. With several Phase 2 readouts for autoimmune and oncology programs slated for the second half of 2026, the market is currently in a “wait and see” mode regarding the company’s transition from a research pioneer to a diversified commercial powerhouse.

Daily Market Movers: US & Canada Top Movers (March 12, 2026)

Lightwave Logic Inc. (LWLG): $7.08 USD, +41.04% (+$2.06 USD), Technology. The stock skyrocketed on massive volume as the company announced a breakthrough in its electro-optic polymer platform, achieving industry-leading stability and speed for 800G and 1.6T optical transceivers. Investors are betting on LWLG becoming a cornerstone supplier for the next wave of high-speed AI data center interconnects.

ProFrac Holding Corp. (ACDC): $6.96 USD, +18.77% (+$1.10 USD), Energy. Shares surged as WTI crude oil prices approached $100 per barrel following supply disruption fears in the Middle East. As a leading energy services provider, ProFrac is seeing increased demand for hydraulic fracturing fleets as domestic producers accelerate drilling activity to capitalize on the price spike.

Celanese Corp. (CE): $59.60 USD, +14.75% (+$7.66 USD), Basic Materials. The chemical giant saw a sharp recovery as it announced a strategic restructuring of its acetyl chain business and a long-term supply agreement with a major EV battery manufacturer. The market reacted positively to the improved margin outlook and the company’s deepening ties to the energy transition supply chain.

LSB Industries Inc. (LXU): $15.44 USD, +14.37% (+$1.94 USD), Basic Materials. The stock climbed as rising natural gas prices—a key input for competitors—and tightening global fertilizer supplies drove expectations for higher selling prices. LXU’s focus on low-carbon ammonia production is also attracting ESG-focused capital as industrial demand for green hydrogen feedstock ramps up.

Kosmos Energy Ltd. (KOS): $2.28 USD, +13.43% (+$0.27 USD), Energy. The independent oil and gas producer rallied alongside the broader energy sector as geopolitical risks in the Persian Gulf threatened global supply. Investors were particularly focused on Kosmos’s offshore projects in West Africa, which are seen as increasingly critical “stable” alternatives to Middle Eastern supply.

CF Industries Holdings Inc. (CF): $136.00 USD, +13.21% (+$15.87 USD), Basic Materials. CF Industries hit near 52-week highs as a global scramble for nitrogen fertilizers intensified. The company is benefiting from a “perfect storm” of rising agricultural commodity prices and its own cost-advantaged North American production base compared to European peers facing high energy costs.

Occidental Petroleum Corp. (OXY): $58.41 USD, +5.09% (+$2.83 USD), Energy. Shares surged to a new 52-week high as Brent crude prices touched $100 per barrel following escalating geopolitical tensions and a vow from Iran to keep the Strait of Hormuz closed. The stock received an additional boost from a double upgrade by Piper Sandler (to Overweight) and Wells Fargo, with analysts highlighting the company’s superior capital efficiency in the Permian Basin and its strategic “physical AI” positioning as a domestic energy provider for future data center power needs.

Exxon Mobil Corp. (XOM): $153.53 USD, +1.29% (+$1.95 USD), Energy. Shares trended higher as Brent crude surged past $100 per barrel due to escalating tensions in the Middle East and the evacuation of non-essential staff from regional operations. The stock’s momentum was further bolstered by a significant price target hike from Piper Sandler—raising it to $186 from $145—and a unanimous board recommendation to redomicile the company from New Jersey to Texas to leverage a more favorable regulatory environment.

Suncor Energy Inc. (SU): $81.46 CAD, +2.98% (+$2.36 CAD), Energy. The stock hit a new 52-week high on the Toronto Stock Exchange as investors pivoted to Canadian oil sands as a “safe haven” amid escalating Middle East conflicts and a surge in Brent crude past $100 per barrel. Beyond the geopolitical premium, the rally was fueled by the official launch of Suncor’s renewed C$3.3 billion share buyback program and a price target hike from CIBC to C$88, with analysts citing the company’s aggressive 10% increase in monthly repurchases as a primary driver for EPS growth in 2026.

Kosmos Energy Ltd. (KOS): $2.28 USD, +13.43% (+$0.27 USD), Energy. The stock rebounded sharply on Thursday following the close of its $185.3 million public offering and news of significant insider buying. CEO Andrew Inglis and Director Adebayo Ogunlesi purchased a combined $6.6 million in shares, signaling strong internal confidence despite recent dilution. The recovery was also supported by surging Brent crude prices and a positive market reaction to the company’s plan to use offering proceeds to aggressively pay down its multi-billion dollar debt load.

📉 Top Losers – WebKarobar Daily Market Movers

Navitas Semiconductor Corp. (NVTS): $9.98 USD, -7.93% (-$0.86 USD), Semiconductors. The stock pulled back on Thursday as investors locked in profits following Wednesday’s massive 25% surge. Despite the daily dip, sentiment remains buoyed by the launch of the 5th-generation GeneSiC platform and new 1200V MOSFETs designed to slash heat dissipation in AI data center server racks. Analysts note that while the pivot away from low-margin mobile markets is compressing near-term revenue, the company’s strategic positioning within Nvidia’s 800V AI factory ecosystem makes it a high-beta favorite for the infrastructure build-out.

Incannex Healthcare Inc. (IXHL): $3.08 USD, -48.41% (-$2.89 USD), Healthcare. The stock plummeted on Thursday after the company announced the pricing of a $10 million registered direct offering of 2,000,000 shares and warrants at a combined price of $5.00. While the capital is intended to fund the completion of the DReAMzz Phase 2 study for its sleep apnea drug IHL-42X, the market reacted sharply to the substantial dilution and the fact that the offering was priced significantly below the previous close. Sentiment was further weighed down by the company’s decision to terminate its at-the-market (ATM) facility, reducing future financing flexibility as it eyes a Phase 3 transition in 2027.

WELL Health Technologies Corp. (WELL): $4.08 CAD, -1.69% (-$0.07 CAD), Healthcare. The stock eased lower on Thursday as investors adjusted positions ahead of the company’s year-end 2025 financial results scheduled for March 19. Despite the minor pullback, sentiment remains positive following recent reports of record patient visits and a strategic expansion of its credit facility to fund further AI-driven healthcare acquisitions. Analysts maintain a strong buy rating with a consensus price target of $7.78, viewing the current consolidation as a potential entry point before the next phase of its “WELL Star” platform IPO.

Vertex Pharmaceuticals Inc. (VRTX): $478.13 USD, -2.89% (-$14.25 USD), Healthcare. Shares pulled back on Thursday as investors locked in profits following a massive 8.4% surge earlier in the week sparked by “unprecedented” Phase 3 interim results for its kidney disease drug, povetacicept. Despite the daily decline, the stock remains a top institutional pick as it successfully transitions from a cystic fibrosis specialist to a multi-franchise leader, bolstered by the blockbuster launch of its non-opioid pain treatment, suzetrigine. Analyst sentiment remains overwhelmingly bullish, with Oppenheimer and Morgan Stanley recently hiking price targets to $600 and $596 respectively, citing the company’s superior 35.2% net margins and a pipeline that is now silencing long-term skeptics.

Daily Market Movers: US & Canada Top Movers (March 11, 2026)

Navitas Semiconductor Corp. (NVTS): $10.84 USD, +24.88% (+$2.16 USD), Semiconductors. The stock surged as the company unveiled its next-generation GaNSafe and GeneSiC technology specifically designed for AI data center power supplies. Investors rallied behind the specialized power semiconductors, which are increasingly seen as essential infrastructure for reducing the massive energy footprint of Blackwell-class AI server clusters. This high-volume move marks a significant breakout as Navitas positions itself as a critical efficiency play in the global “Physical AI” and robotics supply chain.

Nebius Group N.V. (NBIS): $112.00 USD, +16.14% (+$15.57 USD), Technology. The stock catapulted after NVIDIA announced a massive $2 billion strategic investment in the company. This partnership establishes a deep engineering collaboration to build out “AI Factories” and hyperscale cloud infrastructure, with Nebius planning to deploy over 5 gigawatts of NVIDIA-powered compute capacity by 2030. The deal cements Nebius as a premier “neocloud” winner, specifically optimized for the burgeoning era of Agentic AI and large-scale inference workloads.

Acurx Pharmaceuticals Inc. (ACXP): $6.03 USD, +107.93% (+$3.13 USD), Healthcare. The stock experienced a massive triple-digit breakout as the company officially signaled its transition into a late-stage clinical powerhouse. Momentum was driven by the launch of a new pilot trial for ibezapolstat targeting recurrent C. difficile (rCDI) and the confirmation that their global Phase 3 program has secured the necessary regulatory green lights from the FDA and EMA. Investor confidence was further bolstered by management’s decision to take voluntary 10% salary cuts to preserve capital for upcoming trials, coupled with the re-highlighting of a staggering 96% clinical cure rate from earlier studies. With a major financial and business update scheduled for March 13, the market is aggressively pricing in the company’s path toward commercialization.

XCF Global Inc. (SAFX): $0.50 USD, +74.50% (+$0.21 USD), Energy/Renewable Fuels. The stock skyrocketed after the company secured critical shareholder approval to remove a “Share Cap” on its equity issuance, clearing the path for a $10 million strategic investment from EEME Energy. This funding is earmarked for the conversion of the New Rise Reno facility into a dedicated Sustainable Aviation Fuel (SAF) production hub. Beyond the immediate cash infusion, investors are reacting to the company’s progress on a transformative three-party merger with Southern Energy Renewables and DevvStream, which aims to create the first publicly traded, vertically integrated SAF platform in the U.S. with a production capacity goal of 80 million gallons per year by 2028.

60 Degrees Pharmaceuticals Inc. (SXTP): $3.22 USD, +71.28% (+$1.34 USD), Healthcare. The stock skyrocketed after the company announced that all three patients in its expanded-access clinical trial for relapsing babesiosis were successfully cured using its tafenoquine-based regimen. The results, which showed a near 100% cure rate when combining trial data with prior studies from the Yale School of Public Health, have prompted the company to call for a formal review of existing treatment guidelines for the tick-borne illness. This clinical breakthrough is a major milestone for the company’s lead drug, ARAKODA, potentially expanding its market use beyond malaria prevention into a life-saving treatment for immunosuppressed patients.

Paranovus Entertainment Technology Ltd. (PAVS): $2.28 USD, +62.86% (+$0.88 USD), Technology/E-commerce. The stock experienced a massive surge as a potential short squeeze took hold, fueled by an astronomical short interest of over 60%. Investors are reacting to the company’s aggressive pivot into AI-powered entertainment and TikTok e-commerce solutions, which recently delivered a staggering 18,037% year-over-year revenue increase. This momentum is further supported by the successful completion of a strategic overhaul, including a 1-for-100 reverse split and a move into the high-growth “neocloud” and digital branding space. With technical indicators flashing buy signals and the company regaining Nasdaq compliance, the stock is becoming a focal point for traders looking for high-octane growth in the Agentic AI and social commerce sectors.

Actelis Networks Inc. (ASNS): $0.56 USD, +47.57% (+$0.18 USD), Technology/Networking. The stock surged after the company announced a significant order from a Japanese governmental entity to supply dozens of its MetaLight networking units. The deal supports critical infrastructure modernization across Japan’s transportation, utilities, and public safety sectors, with potential extensions into defense-related installations. Actelis’ hybrid fiber-copper technology is proving to be a high-demand solution for agencies looking to achieve fiber-grade connectivity over legacy wiring without the disruption of new construction. This win follows a massive 250% rally earlier in the month tied to a Caltrans highway project, signaling a sustained trend of government-led “Physical AI” and IoT infrastructure upgrades.

Roma Green Finance Ltd. (ROMA): $4.83 USD, +39.19% (+$1.36 USD), Industrials/ESG Consulting. The Hong Kong-based ESG specialist experienced a significant rally as momentum buyers returned to the ticker following a period of high volatility earlier in the year. While no major new filings were released on Wednesday, the stock benefited from a broader sector rotation into sustainability and climate-risk advisory services. Technical traders noted the stock’s strength as it broke through key resistance levels, supported by its zero-debt balance sheet and impressive 60% year-over-year revenue growth. This move solidifies ROMA as a speculative favorite in the small-cap ESG space, particularly as companies globally ramp up compliance ahead of new 2026 reporting standards.

DigitalOcean Holdings Inc. (DOCN): $68.69 USD, +10.77% (+$6.68 USD), Technology/Cloud Computing. The cloud provider for SMBs surged as a high-profile partnership with Workato showcased the power of its “Agentic Inference Cloud.” Workato’s AI Research Lab selected DigitalOcean’s NVIDIA Hopper GPU-powered platform to run enterprise-scale AI agents, highlighting significant cost savings and performance gains over hyperscale competitors. This validation of DigitalOcean’s infrastructure for production-grade AI workloads, combined with a string of price target hikes from firms like Oppenheimer ($85) and Goldman Sachs ($78) following its recent earnings beat, has solidified the stock as a top-tier play for investors targeting the intersection of cloud services and autonomous AI.

Tesla Inc. (TSLA): $407.82 USD, +2.15% (+$8.59 USD), Consumer Cyclical/EV. The stock rose as investors rallied behind a surge in China sales, with February deliveries from Giga Shanghai jumping 91% year-over-year. Momentum was further amplified by Elon Musk’s announcement of a new joint project with xAI called “Digital Optimus” (or Macrohard), a system designed to use Grok-based reasoning to automate complex enterprise and clerical tasks. While some analysts raised concerns about a potential third year of delivery declines, the market shifted focus toward the accelerating “Physical AI” narrative, bolstered by teasers of human-like “Gen 3” dexterous hands for the Optimus robot and the wide rollout of FSD v13, which data shows has achieved a 95% reduction in disengagements.

Trilogy Metals Inc. (TMQ.TO): $5.62 CAD, +1.44% (+$0.08 CAD), Basic Materials. The Alaskan-focused copper developer edged higher as investors digested the U.S. Department of the Interior’s decision to open 2.1 million acres in the Dalton Corridor. This move effectively removes a major land-status barrier for the Ambler Access Project (the 211-mile industrial road), which is the critical catalyst for unlocking Trilogy’s high-grade Arctic and Bornite deposits. Despite a wider fiscal 2025 net loss due to non-cash accounting charges from a $17.8 million federal investment, the market remains focused on the company’s fully-funded $35 million 2026 budget. This “Growth Radar” favorite is now aggressively moving toward mine permit submissions for the Arctic Project, leveraging expedited federal frameworks to secure its position in the domestic critical minerals supply chain.

Novavax Inc. (NVAX): $10.80 USD, +1.03% (+$0.11 USD), Healthcare/Biotechnology. The stock is trending as it completes its transformation into a high-margin licensing engine, marked by its first full year of GAAP profitability in 2025 with $440 million in net income. Investors are rallying behind the company’s pivot toward an asset-light model, leveraging its proprietary Matrix-M adjuvant technology through massive global partnerships with Sanofi and Pfizer to drive long-term, non-dilutive revenue.

Enovix Corp (ENVX): $5.01 USD, +1.42% (+$0.07 USD), Technology/Electrical Equipment. The stock is trending as investors monitor the company’s aggressive manufacturing pivot at Fab2 in Malaysia, where a leadership overhaul and new ISO 9001:2015 certification have signaled a transition from R&D to high-volume “Physical AI” battery production.

📉 Top Losers – WebKarobar Daily Market Movers

Nio Inc. (NIO): $5.47 USD, -4.04% (-$0.23 USD), Consumer Cyclical/EV. Shares cooled as investors locked in profits following a massive 15% surge the previous day. Despite the dip, the sentiment remains anchored by Nio’s historic milestone—its first-ever quarterly net profit of $40.4 million—and a massive 76% revenue jump. While some analysts remain cautious on long-term margins, the company’s aggressive Q1 delivery guidance of 83,000 units suggests a fundamental pivot from “growth-at-all-costs” to a sustainable, profitable production model.

Aecon Group Inc. (ARE.TO): $41.45 CAD, -1.14% (-$0.48 CAD), Industrials. Shares saw a minor retracement on Thursday as the market digested a massive 7.5% surge from the prior session. Despite the slight dip, investor sentiment remains bullish following the company’s robust Q4 earnings report, which highlighted a record-breaking $10 billion backlog. The construction giant is benefiting from a strategic pivot toward high-margin energy transition and utility infrastructure projects, which now represent over 60% of its total revenue. Analysts noted that the current valuation remains attractive as Aecon leverages its dominant position in Canada’s nuclear refurbishment and transportation sectors to drive long-term cash flow growth.

AeroVironment, Inc. (AVAV): $207.73 USD, -6.25% (-$13.84 USD), Defense. Shares slipped as the market reacted to a $200 million stock offering to fund “Physical AI” R&D. Despite the dilution dip, the company is coming off a massive Q3 earnings beat and a record $463 million backlog. The decline is seen as a technical breather after recent all-time highs, with the core narrative still focused on surging global demand for its Switchblade autonomous drone systems.

Quantum BioPharma Ltd. (QNTM): $2.10 USD, -25.00% (-$0.70 USD), Healthcare. Shares cratered to an all-time low after the company revised its $4 million private placement terms, significantly lowering conversion and warrant prices. While the firm is pushing toward Phase 2 trials for its Lucid-MS candidate, the market is aggressively pricing in the heavy shareholder dilution required to fund operations and its ongoing $700 million legal battle against major financial institutions.

Daily Market Movers: US & Canada Top Movers (March 10, 2026)

NVIDIA Corp (NVDA): $184.77 USD, +1.16% (+$2.12 USD), Semiconductors/AI. The AI titan edged higher on Tuesday as anticipation builds for the GTC 2026 conference next week, where CEO Jensen Huang is expected to detail the “agentic AI” roadmap. While the stock has essentially traded sideways in early 2026 despite record-shattering Q4 revenue of $68.1 billion, bulls are focusing on the massive Blackwell supply commitments, which have nearly doubled to $95.2 billion. BofA Securities recently reiterated a $300 price target, noting that the stock’s forward P/E of 17x represents a historical low relative to its 70%+ projected growth. Further excitement stems from the launch of NemoClaw, an open-source platform for AI agents, signaling Nvidia’s shift from a hardware provider to a foundational software ecosystem. Despite the optimism, some analysts warn that “priced to perfection” expectations for the upcoming Rubin architecture could lead to short-term volatility if the GTC keynote lacks a major “thesis-altering” surprise.

AXT Inc. (AXTI): $44.30 USD, +14.89% (+$5.74 USD), Semiconductors. The compound semiconductor specialist rebounded sharply as investors looked past a wave of heavy insider selling from the previous week. While CEO Morris Young and Director Jesse Chen offloaded nearly $12 million in shares collectively between March 4 and March 9, buyers returned on Tuesday to capitalize on the sustained demand for indium phosphide (InP) substrates used in AI data centers. Analysts from Wedbush and Northland maintain aggressive price targets of $28 and $35, respectively, citing AXT’s critical role in high-speed optical transceivers for Google and Amazon. Despite the recovery, the stock remains highly volatile near its 52-week high, with broader concerns lingering over China-related export permit delays and a Q4 revenue guidance cut.

Figure Technology Solutions Inc. (FIGR): $39.59 USD, +21.29% (+$6.95 USD), Financial Technology. The blockchain-native fintech surged as investors breathed a sigh of relief following the expiration of the IPO lock-up period on March 10, 2026. Despite fears of a mass sell-off, the stock rallied on “relief” buying and a robust February operating update showing a 127% year-over-year jump in consumer loan volume to $896 million. Investor sentiment was further bolstered by the company’s recent launch of the world’s first fully on-chain public equity offering and a newly authorized $200 million share buyback program. While Mizuho recently trimmed its price target to $55, it maintained an “Outperform” rating, citing Figure’s high-margin expansion into the $670 billion auto-loan market. The stock remains a favorite for those betting on the “tokenization of everything,” even as it faces short-term volatility from a recent Q4 earnings miss.

VNET Group Inc. (VNET): $11.23 USD, +14.71% (+$1.44 USD), Technology/Data Centers. The China-based carrier-neutral data center provider surged as investors positioned themselves ahead of the company’s Q4 and full-year 2025 earnings release scheduled for March 16. Sentiment was further electrified by news that VNET recently secured a massive 500MW capacity order from ByteDance, the largest in its history, highlighting the explosive demand for AI-ready infrastructure in the region. To fuel this expansion, the company recently closed a $138 million private placement and is leveraging a new “green” REIT structure on the Shanghai Stock Exchange to recycle capital. While analysts at Zacks and Morningstar remain cautious due to a revised lower EPS consensus, the stock is currently trading near 52-week highs, supported by a “bull case” valuation of $15.31 as it pivots aggressively toward wholesale AI data center (AIDC) services.

BridgeBio Pharma Inc. (BBIO): $74.32 USD, +13.22% (+$8.68 USD), Healthcare/Biotechnology. The genetic disease specialist surged to near-all-time highs as investors moved in ahead of a high-stakes “late-breaker” presentation at the MDA Clinical & Scientific Conference scheduled for Wednesday, March 11. Momentum was further ignited by William Blair initiating coverage with an “Outperform” rating and a $93 fair value estimate, labeling the firm a “de-risked” commercial powerhouse. Traders are specifically focused on the final Phase 3 FORTIFY data for BBP-418, which targets a rare muscular dystrophy (LGMD2I/R9) and is slated for an FDA submission in the first half of 2026. This technical breakout follows a period of consolidation and heavy insider selling, as the market begins to price in a “triple-submission” runway for 2026 that includes therapies for ADH1 and achondroplasia alongside the accelerating commercial launch of Attruby.

Nio Inc. (NIO): $5.70 USD, +15.38% (+$0.76 USD), Consumer Discretionary/EV. The Chinese electric vehicle maker achieved a historic milestone on Tuesday, reporting its first-ever quarterly net profit since its inception in 2014. For Q4 2025, Nio posted a net income of $40.4 million, driven by record-breaking deliveries of 124,807 vehicles—a 71.7% year-over-year surge. The financial turnaround was bolstered by an optimized product mix and significant cost-cutting in R&D, pushing vehicle margins to 18.1%. Management provided aggressive Q1 2026 guidance, projecting deliveries to nearly double year-over-year. Following the report, Nomura upgraded the stock to “Buy” with a $6.60 price target, while Citigroup highlighted falling battery costs as a long-term tailwind. Despite the rally, investors remain cautious regarding a newly approved 2026 stock incentive plan for CEO William Li, which could grant him up to 248 million shares if high-performance targets are met.

Rivian Automotive Inc. (RIVN): $16.54 USD, +4.22% (+$0.67 USD), Consumer Discretionary/EV. The electric vehicle manufacturer climbed as TD Cowen upgraded the stock from “Hold” to “Buy” with a $20 price target, citing a massive potential “Model 3 moment” for the upcoming R2 SUV. Analysts estimate the more affordable R2 could drive annual demand between 212,000 and 335,000 units, significantly outpacing current Wall Street projections for 2027. This bullish sentiment comes just days before the R2’s full reveal at SXSW in Austin on March 12, where the company is expected to open the configurator for a vehicle priced near $45,000. Despite a year-to-date decline of nearly 15%, the rally was further supported by a surprise 9% GAAP gross margin in the most recent quarter and progress on Rivian’s in-house AI processors for autonomous driving. While some firms like JPMorgan remain cautious with lower targets, the market is currently rewarding Rivian’s pivot from a niche luxury player to a high-volume Tesla competitor.

Maze Therapeutics Inc. (MAZE): $51.06 USD, +13.30% (+$5.99 USD), Healthcare/Biotechnology. The clinical-stage biotech hit a fresh all-time high on Tuesday following a major “Outperform” initiation from Mizuho, which set a street-high price target of $97. Analysts pointed to the company’s “Compass” platform as a uniquely de-risked approach to precision medicine, specifically highlighting the upcoming Phase 2 data for MZE829 in APOL1-mediated kidney disease. Investor sentiment has also been bolstered by a “rebound” narrative after the FTC previously blocked its Sanofi partnership, as the market now values Maze’s ability to commercialize its Pompe disease and CKD assets independently. While the stock has surged over 330% in the last year, the current breakout above $50 signals strong institutional conviction ahead of several key mid-2026 clinical readouts.

BridgeBio Pharma Inc. (BBIO): $74.32 USD, +13.22% (+$8.68 USD), Healthcare/Biotechnology. The genetic disease specialist surged to a technical breakout as William Blair initiated coverage with an “Outperform” rating and a $93.03 fair value estimate. Analysts labeled the firm a “de-risked” commercial powerhouse, citing the accelerating launch of Attruby and a “triple-submission” regulatory runway for 2026. Momentum is peaking ahead of a high-stakes “late-breaking” oral presentation at the MDA Clinical & Scientific Conference on Wednesday, March 11, where the company will reveal expanded Phase 3 FORTIFY data for BBP-418 (targeting limb-girdle muscular dystrophy). With an FDA filing for BBP-418 expected in the first half of 2026 and additional submissions planned for encaleret and infigratinib, the market is aggressively pricing in BridgeBio’s transition from an R&D-heavy biotech to a multi-product commercial leader.

5N Plus Inc. (VNP): $29.17 CAD, +3.37% (+$0.95 CAD), Materials/Specialty Semiconductors. The Montreal-based supplier of essential semiconductor materials rebounded on Tuesday, snapping a four-day losing streak as investors weighed its dominant role in the AI and space-solar supply chains. The stock’s recovery follows a “record-setting” 2025 fiscal report where revenue surged 44% and net debt was halved. Management has issued a robust 2026 outlook, targeting adjusted EBITDA between $100 million and $105 million, fueled by a 25% capacity expansion at its AZUR SPACE subsidiary to meet “insatiable” demand for satellite and AI-driven terrestrial solar power. While the firm warned of normalized margins for bismuth-based products and rising input costs, analysts remain bullish; Desjardins and Mizuho maintain “Buy” ratings with price targets reaching as high as $36.86. A recent $18.1 million U.S. government grant for germanium recycling at its Utah facility further cements 5N Plus as a critical pillar in the Western semiconductor “de-risking” narrative, making it a favorite for 2026 growth portfolios.

📉 Top Losers – WebKarobar Daily Market Movers

FingerMotion Inc. (FNGR): $1.20 USD, -2.85% (-$0.035 USD), Technology/Software. The mobile services specialist drifted lower on Tuesday as it continues to navigate a challenging transition toward a more diversified business model. Investor sentiment remains cautious following the company’s Q3 fiscal 2026 results, which revealed a 32% year-over-year revenue decline to $5.80 million and persistent net losses of $1.67 million. While management is pivoting resources toward the higher-margin Command and Communication segment and recently signed a memorandum of understanding to explore a North American marketplace initiative, capital constraints have hindered promotional activities for its core DaGe platform. Despite these headwinds, the company recently re-elected its board and re-appointed CEO Martin Shen at its February annual meeting, signaling leadership stability. Analysts at StockInvest.us have recently downgraded the stock to a “Sell Candidate,” noting that while it finds support near $1.13, it currently holds several negative technical signals and faces a short cash runway of less than one year.

Boeing Co. (BA): $217.76 USD, -3.22% (-$7.24 USD), Industrials/Aerospace. Shares of the planemaker fell on Tuesday after the company disclosed that a wiring defect discovered in several 737 MAX aircraft will cause near-term delivery delays. The issue, traced to a machining error that resulted in small scratches on the wiring, requires “rework” on a specific group of undelivered jets to ensure they meet quality standards. While Boeing maintained its full-year 2026 delivery goal of roughly 500 MAX planes, the setback complicates efforts to demonstrate manufacturing discipline to the FAA following years of heightened oversight. The negative price action overshadowed news of a $289 million direct commercial sale to Israel for 5,000 Small Diameter Bombs and ongoing reports of a potential 500-jet order from China. Analysts remain cautiously optimistic about the long-term recovery under CEO Kelly Ortberg, though this latest “hiccup” serves as a reminder of the persistent operational hurdles facing the Everett production lines.

Lockheed Martin Corp. (LMT): $651.22 USD, -1.95% (-$12.93 USD), Industrials/Defense. Shares of the defense giant retreated on Tuesday as investors reacted to President Trump’s recent optimistic comments suggesting the Middle East conflict could be “pretty much complete.” The potential for a faster-than-expected de-escalation triggered a broader “peace pivot” in the defense sector, with Lockheed serving as a primary barometer for investor sentiment. Despite the daily dip, the company remains fundamentally active, announcing a new incentive agreement with the state of Alabama to expand its Pike County munitions facility to meet rising demand for JASSM and LRASM missiles. Additionally, its Sikorsky unit unveiled the R66 TURBINETRUCK, an autonomous cargo helicopter developed with Robinson Helicopter, marking the 21st aircraft to integrate Lockheed’s MATRIX autonomy system. While analysts at Zacks maintain a “Value” score for the long term, the stock is currently navigating short-term volatility as traders weigh record defense spending against shifting geopolitical headlines.

General Dynamics Corp. (GD): $355.59 USD, -1.77% (-$6.39 USD), Industrials/Defense. Much like its peer Lockheed Martin, General Dynamics saw its recent “geopolitical premium” soften on Tuesday as traders reacted to the potential de-escalation of the Iran conflict. Despite the daily dip, the company underscored its long-term value by announcing a 6% increase in its quarterly dividend to $1.59 per share, payable in May 2026. Fundamentally, the company remains on a tear; its Gulfstream G700 recently received certification in India, clearing a major path for international deliveries of its flagship jet. While its aerospace and marine segments have faced occasional execution hurdles and supply-chain delays, analysts remain bullish on GD’s $115 billion unspent budget authority and the ramp-up of the Columbia-class submarine program. With a consensus “Buy” rating and a focus on high-margin G700 deliveries, the stock continues to be a staple for defensive growth portfolios despite the short-term noise.

Constellation Energy Corp (CEG): $317.09 USD, -1.83% (-$5.90 USD), Utilities/Energy. The leading nuclear power producer drifted lower on Tuesday as part of a broader consolidation following its record-breaking 17.5% surge in February. Investor focus is shifting toward the company’s upcoming 2026 Business and Earnings Outlook conference call scheduled for March 31, where management is expected to detail the integration of the recently acquired Calpine fleet. Despite the minor pullback, CEG remains a top “AI energy” pick; the company recently secured a 380MW deal with CyrusOne to power a Texas data center and continues to benefit from its 20-year nuclear supply agreements with Microsoft and Meta. Analysts at TD Cowen recently raised their price target to $454, citing a likely acceleration in power contracting and the massive potential of the “Powered Land” strategy. Currently trading at roughly 28x forward earnings, the stock is navigating a high-valuation environment while the market awaits a $1 billion DOE loan guarantee to finalize the restart of the Crane Clean Energy Center (Three Mile Island).

Exxon Mobil Corp (XOM): $148.13 USD, -1.52% (-$2.28 USD), Energy/Oil & Gas. Shares of the energy giant drifted lower on Tuesday as crude oil prices pulled back sharply from recent highs following President Trump’s comments suggesting an accelerated timeline for de-escalation in the Middle East. The downward move coincided with the company’s March 10 dividend payment ($1.03/share) and a strategic announcement that the Board has recommended redomiciling the company’s legal home from New Jersey to Texas. While the redomiciliation is intended to streamline regulatory oversight, investors were more focused on the broader “peace pivot” that saw WTI crude tumble toward $87. Despite the daily dip, Exxon remains fundamentally robust, with its Guyana production recently surpassing 900,000 barrels per day and analysts at BofA and Citi recently raising their price targets to $151 and $150, respectively. The stock continues to be viewed as a premier defensive play, supported by a $20 billion share buyback program for 2026 and industry-leading low-cost production in the Permian and Stabroek blocks.

Palantir Technologies Inc. (PLTR): $151.14 USD, -3.38% (-$5.29 USD), Software/Data Analytics. The AI powerhouse drifted lower on Tuesday as part of a broader “SaaSpocalypse” sell-off hitting high-valuation software names. Despite reporting explosive 70% year-over-year revenue growth in its latest quarter and a record $4.3 billion in total contract value, the stock is currently a battleground for valuation skeptics. Analysts from The Motley Fool and Nasdaq have warned that even with its 121% surge in U.S. commercial revenue, a forward P/E ratio exceeding 160 leaves “no room for error.” Adding to the volatility, some investors are rotating out of defense-linked tech following recent de-escalation rhetoric in the Middle East. While bulls like Wedbush and Bank of America maintain price targets as high as $255—citing its unique “Ontology” moat and a recent partnership with Polymarket—the stock remains 25% below its November highs as the market tests its ability to sustain 60%+ growth through 2026.

Daily Market Movers: US & Canada Top Movers (March 9, 2026)

Xenon Pharmaceuticals Inc. (XENE): $62.76 USD, +49.64% (+$20.82 USD), Healthcare/Biotechnology. The neuroscience specialist delivered what analysts called a “best-in-class” result for its Phase 3 X-TOLE2 study of azetukalner. The trial showed a remarkable 53.2% reduction in monthly seizure frequency for epilepsy patients, far exceeding the 10.4% seen in the placebo group. Following the news, Baird and Jefferies aggressively raised their price targets to $97 and $100 respectively, anticipating an FDA filing in Q3 2026. Despite the rally, the company capitalized on the momentum by announcing a $500 million secondary stock offering to fuel its commercial launch.

Autozi Internet Technology (Global) Ltd. (AZI): $0.65 USD, +146.40% (+$0.39 USD), Consumer Discretionary/Automotive. The Beijing-based automotive service provider skyrocketed on Monday after announcing that its controlling shareholder fulfilled a $7 million capital injection commitment. Market enthusiasm was further amplified by a proposal from the shareholder and co-investors to invest an additional $110 million at a price of $1.30 per share—a massive premium compared to its recent trading levels. This funding is earmarked for expanding its aftermarket service network and upgrading its digital platform with AI and big data tools, providing a critical liquidity buffer for the micro-cap firm.

Relmada Therapeutics Inc. (RLMD): $7.17 USD, +61.12% (+$2.72 USD), Healthcare/Biotechnology. The clinical-stage biotech saw a massive surge on Monday after announcing durable 12-month interim data from its Phase 2 trial of NDV-01 for high-risk bladder cancer. The study reported a 76% complete response (CR) rate at one year, with a particularly strong 80% CR in the difficult-to-treat BCG-unresponsive population. Parallel to the data, Relmada secured an oversubscribed $160 million private placement (PIPE) from elite institutional investors like OrbiMed and RA Capital, providing the “war chest” needed to advance into Phase 3 registrational trials mid-year.

AN2 Therapeutics Inc. (ANTX): $5.25 USD, +84.21% (+$2.40 USD), Healthcare/Biotechnology. The clinical-stage biopharma shares surged to a new 52-week high on Monday following the announcement of a $40 million private placement financing. The deal, which includes participation from high-profile institutional investors like Coastlands Capital and Vivo Capital, provides a critical “capital infusion” to advance its lead candidate, epetraborole. This momentum is further bolstered by the company’s recent pivot to initiate a Phase 2 study for Polycythemia Vera (PV) in Q3 2026, a move supported by data showing the drug’s unique ability to provide sustained hematocrit reduction in rare blood cancer patients.

XCF Global Inc. (SAFX): $0.32 USD, +46.20% (+$0.10 USD), Energy/Renewable Fuels. The Sustainable Aviation Fuel (SAF) producer surged on Monday following a weekend of high-volume accumulation after the company cleared a major regulatory hurdle for its “New Rise Reno 2” facility. The market is reacting to XCF’s aggressive expansion strategy, which includes a planned $300 million investment to double its production capacity to 80 million gallons annually. Despite recent Nasdaq compliance warnings regarding its bid price, investors are piling back into the “decarbonization” play, betting on the company’s ability to capitalize on the 2026 global mandate shift where airlines are now required to hit a 2% SAF blend.

EON Resources Inc. (EONR): $0.80 USD, +19.40% (+$0.13 USD), Energy/Oil & Gas. The Permian Basin producer surged on Monday as it continues to be treated as a high-conviction “security hedge” against Middle East supply volatility. The rally is supported by the company’s aggressive 2026 turnaround strategy, which includes a transition to horizontal drilling and a recently expanded hedging position covering 60% of its 2026 production at prices above $60.00 per barrel. With heavy insider buying—totaling over 1.5 million shares since late 2025—and a significant debt reduction program, investors are increasingly betting on EONR as a high-momentum domestic energy play for the current “triple-digit oil” environment.

Nuvve Holding Corp. Warrant (NVVEW): $0.0088 USD, +76.00% (+$0.0038 USD), Energy/Grid Technology. The vehicle-to-grid (V2G) specialist’s warrants exploded on Monday following a Friday announcement of a massive strategic partnership with OMNIA Global. The deal aims to address a development pipeline exceeding 1 GW over the next 24 months, starting with a 50MW battery storage system in Sweden. With potential annual revenues in the Swedish market estimated at up to $325,000 per MW, investors are betting on Nuvve’s transition from a niche EV charging provider to a major player in the high-margin European grid-scale energy storage sector.

Applied Optoelectronics Inc. (AAOI): $110.62 USD, +15.74% (+$15.04 USD), Technology/Hardware. The optical networking leader surged to an 8-year high on Monday after announcing its first volume order for 1.6T data center transceivers from a long-term hyperscale customer. The initial order, valued at over $200 million, marks a critical commercial milestone as AI clusters scale toward higher-speed optics. Analysts at Rosenblatt responded by raising their price target to $140, citing AAOI’s growing domestic manufacturing footprint in Texas and its transition from 800G to 1.6T as a “supercycle” driver for 2026.

MicroStrategy Inc. (MSTR): $138.95 USD, +4.06% (+$5.42 USD), Technology/Digital Assets. The “Bitcoin Proxy” outperformed the broader market on Monday following a dual-announcement that reinforced its aggressive treasury strategy. In an 8-K filing, the company disclosed it acquired 17,994 Bitcoins between March 2 and March 8 for approximately $1.28 billion (average price of $70,946). This purchase was funded through the strategic sale of both common and preferred stock (STRC), bringing its total corporate holdings to a massive 738,731 BTC. Simultaneously, MicroStrategy expanded its enterprise software footprint by launching “Mosaic Sentinel” and “Cloud Cost Arbitrage” at the Gartner Summit, aiming to leverage AI for automated cloud spend optimization.

NVIDIA Corp (NVDA): $182.65 USD, +2.72% (+$4.83 USD), Technology/Semiconductors. The AI bellwether rose on Monday as investors positioned ahead of the GTC 2026 conference (March 16-19), where CEO Jensen Huang is expected to unveil the next-generation Vera Rubin architecture. Confidence was further bolstered by a multi-billion dollar investment and purchase commitment with Lumentum to secure high-bandwidth optical interconnects, ensuring the supply chain remains resilient for the next wave of data center build-outs. Despite recent regulatory headlines, the stock remains a high-conviction play with 2026 revenue projections nearing $216 billion.

Occidental Petroleum Corp (OXY): $55.02 USD, +1.53% (+$0.83 USD), Energy/Oil & Gas. Shares gained ground on Monday as global crude prices spiked toward the $100-per-barrel mark following heightened geopolitical tensions in the Middle East. Beyond the sector-wide tailwind, OXY drew significant attention by successfully settling its upsized $1.2 billion debt buyback and cash tender offers. This aggressive deleveraging, combined with its continued leadership in Direct Air Capture (DAC) through the STRATOS project, keeps the stock positioned as a dual-play on traditional energy demand and long-term carbon management.

NuScale Power Corp (SMR): $12.16 USD, +4.20% (+$0.49 USD), Energy/Nuclear. The small modular reactor (SMR) pioneer finished Monday in the green, shaking off early-session weakness as the broader energy sector rallied amid $100+ oil prices. While the stock remains down significantly from its 2025 highs, it is benefiting from a “flight to domestic power” as the only SMR designer with a Standard Design Approval from the U.S. NRC. Sentiment was also lifted by ongoing collaboration news with Oak Ridge National Laboratory to integrate AI into nuclear fuel management, though gains are being capped by a wave of law firm alerts regarding a pending securities fraud class action related to its ENTRA1 partnership.

Oklo Inc (OKLO): $61.78 USD, +6.06% (+$3.53 USD), Utilities/Advanced Nuclear. The microreactor developer rallied on Monday as the “Nuclear Renaissance” gained fresh momentum. Shares were driven by the announcement of a planned joint venture with Centrus Energy (LEU) to advance HALEU fuel deconversion services at the Piketon, Ohio facility. This strategic move to secure its domestic fuel supply chain, combined with its high-profile 1.2 GW Meta partnership, has analysts reiterating price targets as high as $138.00. While the company remains pre-revenue, investors are betting on its 2026 milestones, including the DOE authorization for its first Aurora deployment in Idaho.

Robinhood Markets Inc (HOOD): $79.35 USD, +2.93% (+$2.26 USD), Financial Services/Fintech. The retail trading giant rallied on Monday following a series of aggressive ecosystem expansions announced at its “Take Flight” event. The most significant catalyst was the launch of the Robinhood Platinum Card, an invite-only premium credit card with a $695 annual fee, designed to capture the “Great Wealth Transfer” by offering 10% back on travel and direct-to-investment reward deposits. Additionally, the firm launched Robinhood Ventures Fund I (RVI), a $650M+ closed-end fund providing retail users access to private markets. These moves, combined with a 57% year-over-year surge in equity trading volume, have analysts targeting a $130.00 consensus price as the company transitions into a full-scale “Financial SuperApp.”

Intel Corp (INTC): $45.58 USD, +4.97% (+$2.16 USD), Technology/Semiconductors. Intel climbed on Monday as market sentiment shifts toward its multi-year “Great Pivot” under the disciplined leadership of CEO Lip-Bu Tan. The rally was largely driven by comments from CFO David Zinsner at a recent technology conference, where he confirmed that the critical 18A (1.8nm) process node is progressing “at or ahead of” internal yield projections. This is a major milestone for Intel Foundry, as the company had previously considered keeping 18A as an internal-only node; however, strong inbound interest for the performance-enhanced 18A-P variant from external customers has reignited hopes for a competitive foundry business that can challenge TSMC.

📉 Top Losers – WebKarobar Daily Market Movers

Innovation Beverage Group Ltd (IBG): $3.31 USD, -40.14% (-$2.22 USD), Consumer Defensive/Beverages. The stock cratered on Monday after the company filed an F-1 registration statement to offer up to 4.17 million units for gross proceeds of $15 million. This massive “best-efforts” offering is highly dilutive, considering the company only had about 1.07 million shares outstanding as of March 5. While $2.5 million of the proceeds are earmarked to fund a loan for its pending merger with BlockFuel Energy, the market reacted violently to the potential influx of new shares and warrants, wiping out nearly all the “nano-float” momentum seen last week.

enGene Holdings Inc (ENGN): $7.05 USD, -18.78% (-$1.63 USD), Healthcare/Biotechnology. The gene therapy firm plummeted on Monday following the dual-threat of a $29.8M quarterly net loss and the launch of a highly dilutive $100 million at-the-market (ATM) share program with Leerink Partners. While the company provided a clinical update on its LEGEND Phase 2 trial for bladder cancer (reporting a 63% complete response rate), the immediate focus of the market shifted to the potential for significant shareholder dilution as the company prepares its Biologics License Application (BLA) for the second half of 2026.

Guardforce AI Co Ltd (GFAI): $0.59 USD, -3.38% (-$0.021 USD), Industrials/Security & AI. The stock remains under pressure as it faces a June 10, 2026, deadline to regain Nasdaq compliance by sustaining a $1.00 share price for at least ten consecutive business days. To combat this, the Board recently authorized a $5 million share repurchase program, signaling management’s belief that the company is undervalued. While its “Smart Retail” robotics partnership in Thailand continues to expand, the stock is currently struggling to find a firm support level amidst broader micro-cap volatility.

Horizon Space Acquisition II Corp (HSPT): $9.30 USD, -2.11% (-$0.20 USD), Financials/SPAC. The blank-check company slipped on Monday as it nears its new March 18, 2026, deadline to complete its merger with SL Bio Ltd, a Taiwan-based biotech firm. While shareholders recently approved the business combination, the stock has been volatile following the redemption of over 6.7 million shares, significantly shrinking the trust account. To maintain momentum, SL Bio’s CEO provided a $50,000 deposit for a one-month extension, with the combined entity expected to list on the Nasdaq under the ticker SLBT once the deal officially closes

BigBear.ai Holdings Inc (BBAI): $4.20 USD, -1.18% (-$0.050 USD), Technology/AI & Defense. BBAI edged lower on Monday, mirroring a broader “risk-off” sentiment in speculative AI names. While the stock is down from its 52-week highs, it recently found some support following its Q4 2025 earnings report. Although revenue of $27.3 million missed estimates, investors were encouraged by a massive 90% debt reduction and a record liquidity position of $462 million. The company is currently pivoting from a custom-consulting model toward a scalable “Agentic AI” platform, bolstered by the integration of Ask Sage, which provides secure generative AI workflows for the U.S. Space Force and other high-security agencies.

Palantir (PLTR): $156.60 USD, +0.11% (Pre-market). PLTR is showing resilience in early trading, clawing back yesterday’s minor loss. While the broader software sector remains volatile due to “Agentic AI” disruption fears, Palantir is benefiting from its “Sovereign AI” narrative and a reported $1B DHS contract expansion. Support is holding firmly at $147.34, with resistance looming at $158.00.

Cisco Systems Inc (CSCO): $76.21 USD, -3.09% (-$2.43 USD), Tech/Networking. Leading the Dow’s tech decline, Cisco is struggling with “margin anxiety” as the cost of AI-ready components (like memory chiplets) spikes. Investors are cautious about management’s ability to maintain high margins while pivoting legacy networking into the AI era.

Klaviyo Inc (KVYO): $20.50 USD, -2.29% (-$0.48 USD), Tech/Software. Klaviyo slipped on Monday despite a major announcement of a deepened Shopify integration to automate global multi-market catalogs. While the stock has faced a “valuation reset” over the last 90 days, it is currently supported by its first-ever $500 million share repurchase program, which includes an immediate $100 million accelerated buyback. Investors are weighing strong 2026 revenue guidance ($1.5B+) and a new Google AI partnership against recent large-scale insider selling, including a $3.7M exit by Co-CEO Andrew Bialecki earlier this month.

Daily Market Movers: US & Canada Top Movers (March 6, 2026)

Samsara Inc. (IOT): $35.36 USD, +19.54% (+$5.78 USD), Technology/Software. The “Connected Operations” leader soared after reporting a decisive “beat and raise” in its Q4 earnings. Investors are rewarding Samsara for its ability to maintain high growth and expand margins even as industrial customers tighten budgets, proving the essential nature of its AI-driven fleet management tools.

Marvell Technology Inc. (MRVL): $89.57 USD, +18.35% (+$13.89 USD), Technology/Semiconductors. Marvell emerged as the primary semiconductor winner after its earnings call highlighted an explosion in demand for AI data center infrastructure. While other chipmakers saw cooling demand, Marvell’s emphatic long-term guidance for its custom silicon and electro-optics business drove a wave of analyst upgrades.

Braiin Ltd. (BRAI): $28.23 USD, +16.41% (+$3.98 USD), Technology/AI. This industrial AI specialist saw a double-digit jump as it gained momentum following new contract wins for its autonomous monitoring systems. The stock is benefiting from a rotation into “Physical AI” companies that provide tangible efficiency gains for global supply chains.

Trio Petroleum Corp. (TPET): $1.90 USD, +21.43% (+$0.34 USD), Energy/Exploration. As WTI Crude prices spiked toward $93/barrel amid escalating conflict in the Middle East, small-cap exploration firms like Trio saw heavy speculative buying. The stock acted as a high-beta vehicle for traders betting on a sustained energy rally driven by supply disruptions near the Strait of Hormuz.

Day One Biopharmaceuticals Inc (DAWN): $21.20 USD, +65.88% (+$8.42 USD), Healthcare/Biotech. Shares of the Brisbane-based biotech skyrocketed after French pharmaceutical giant Servier announced a definitive agreement to acquire the company for $2.5 billion in cash. The $21.50 per share offer price represented a nearly 68% premium, driving DAWN to its highest levels in years as investors cheered the exit for the pediatric oncology specialist.

Peraso Inc (PRSO): $2.04 USD, +151.54% (+$1.23 USD), Technology/Defense. Shares of the mmWave wireless specialist exploded after the company announced its technology was selected for a next-generation military drone identification system. Peraso is seeing massive speculative volume as investors hunt for small-cap plays linked to the increasing electronic warfare needs in the Middle East.

ServiceNow Inc (NOW): $124.34 USD, +3.29% (+$3.96 USD), Technology/Software. Shares of the enterprise software leader climbed as investors reacted positively to the company’s recent launch of its “Autonomous Workforce” solution. By integrating new AI agent capabilities that can resolve IT and HR requests with 99% faster turnaround, ServiceNow is successfully positioning itself as a “must-have” productivity tool for corporations looking to offset rising labor and energy costs. The stock was a rare gainer in the S&P 500 on Friday, outperforming its cloud peers during a broader market slump.

UiPath Inc (PATH): $11.86 USD, +2.68% (+$0.31 USD), Technology/Software. Shares of the automation leader finished higher as the market continues to digest the company’s expansion into “Agentic AI.” Following its recent healthcare-focused AI launch at the ViVE 2026 conference, investors are increasingly viewing PATH as a specialized winner that can automate complex, regulation-heavy workflows that generic AI cannot handle. The stock has gained nearly 8% over the last four trading sessions as it turns toward full-year profitability.

📉 Top Losers – WebKarobar Daily Market Movers

Calidi Biotherapeutics Inc (CLDI): $0.36 USD, −52.73% (−$0.40 USD), Healthcare/Biotech. Shares of the clinical-stage biotech plummeted to a new 52-week low after the company priced a highly dilutive $5.2 million underwritten public offering. The units were priced at just $0.50, a massive discount to Thursday’s closing price, as the company scrambles for working capital to fund its ongoing clinical trials. Existing shareholders were hit hard by the significant dilution and the inclusion of common warrants in the deal.

eLong Power Holding Ltd (ELPW): $0.045 USD, −43.89% (−$0.035 USD), Industrials/Batteries. Shares of the Beijing-based battery tech provider plummeted after the company announced a massive 1-for-80 reverse stock split intended to regain compliance with Nasdaq’s minimum bid price rule. The market reacted negatively to the move, which follows a string of highly dilutive public offerings in February that have already decimated shareholder value. The reverse split is set to take effect on March 12, reducing the total outstanding shares from 63 million to roughly 790,000.

AXT Inc (AXTI): $32.37 USD, −16.56% (−$6.42 USD), Technology/Semiconductors. Shares of the compound semiconductor substrate manufacturer fell sharply as the market reassessed the “AI infrastructure” rally. While AXTI had reached 52-week highs earlier in the week on excitement over indium phosphide demand for AI data centers, Friday’s sell-off was triggered by renewed concerns over Chinese export permits. Investors are growing wary that geopolitical friction could lead to further delays in the company’s ability to ship critical materials from its Chinese manufacturing hubs, leading to a swift retreat from its recent peak.

NVIDIA Corp (NVDA): $177.88 USD, −2.98% (−$5.46 USD), Technology/Semiconductors. Shares of the AI giant slipped as investors reacted to reports of proposed new U.S. export controls that could require special licensing for high-end AI chips (like the GB300 series) sold globally, not just to China. The news sparked fears of increased “red tape” and potential delivery delays for major international hyperscale customers, leading to a pull-back despite NVIDIA’s dominant market position.

Amazon.com Inc (AMZN): $213.12 USD, −2.66% (−$5.82 USD), Technology/E-commerce. Shares of the retail and cloud giant slumped following a series of operational setbacks. The company confirmed a “botched software code deployment” that took down its shopping site and app for over six hours on Thursday, impacting millions in potential sales. Additionally, investor sentiment was dampened by reports that drone strikes linked to the Middle East conflict damaged AWS data centers in the UAE and Bahrain earlier in the week, raising concerns about the physical security of its global cloud infrastructure.

Daily Market Movers: US & Canada Top Movers (March 5, 2026)

The Trade Desk Inc (TTD): $29.79 USD, +18.36% (+$4.62 USD), Technology/Advertising. Shares of the ad-tech giant skyrocketed after the company announced a breakthrough in its post-cookie tracking integration and received a rare “double upgrade” from analysts. TTD is currently benefiting from a rotation back into high-margin software as investors look for “pure play” AI advertising winners.

Sable Offshore Corp (SOC): $13.85 USD, +37.26% (+$3.76 USD), Energy. This small-cap energy player led the sector after reporting a significant discovery in its newest deepwater well. While broader energy markets were volatile due to Iran-related price spikes, SOC’s individual success story allowed it to decouple from the pack and post near-40% gains in a single session.

Tango Therapeutics Inc (TNGX): $16.83 USD, +36.28% (+$4.48 USD), Biotech. TNGX trended heavily following the release of positive early-stage data for its new cancer treatment candidate. Biotech remains a “high growth” focal point in 2026, and Tango’s data was viewed by the market as a significant de-risking event for its entire pipeline.

Broadcom Inc (AVGO): $332.77 USD, +4.80% (+$15.24 USD), Technology/Semiconductors. Broadcom shares surged after the company smashed Q1 2026 earnings expectations, driven by a massive 106% year-over-year explosion in AI revenue. Investors rallied behind CEO Hock Tan’s “spectacular” guidance, which revealed a clear line of sight to over $100 billion in AI chip revenue by 2027. This performance, paired with a new $10 billion share buyback program, has solidified Broadcom’s position as the dominant force in AI networking and custom accelerators.

Healwell AI Inc (AIDX): $0.93 CAD, +19.23% (+$0.15 CAD), Healthcare/AI Technology. AIDX shares surged on the Toronto Stock Exchange yesterday following the major announcement of a multi-million dollar U.S. Health Information Exchange (HIE) contract. This competitive win signals a critical expansion into the U.S. market and reinforces the company’s shift toward high-margin, recurring data infrastructure revenue. The rally, which saw the stock touch a daily high of $1.05, is further fueled by “AI-driven pipeline momentum” and news of the company’s upcoming participation in several major investor conferences (TD Cowen and Scotiabank) throughout March.

Credo Technology Group (CRDO): $114.74 USD, +11.90% (+$12.20 USD), Semiconductors. CRDO staged a powerful rebound as investors shrugged off margin concerns to focus on a 202% year-over-year revenue explosion. With a Zacks #1 Rank and surging demand for AI data center connectivity, the stock is currently a “high-conviction” momentum favorite.

Expedia Group Inc (EXPE): $251.54 USD, +13.69% (+$30.29 USD), Consumer Discretionary. EXPE surged on Thursday as investors rushed to buy shares before the March 5th record date to qualify for its newly boosted $0.48 quarterly dividend (a 20% increase). Beyond the dividend play, the stock is benefiting from a “relief rally” in travel, fueled by a new partnership with PredictHQ for AI-driven demand forecasting and a shift in sentiment after OpenAI reportedly scaled back direct travel checkout plans, reducing competitive fears for traditional online travel agencies.

Tempus AI Inc (TEM): $53.05 USD, +3.43% (+$1.76 USD), Healthcare/AI. TEM shares gained ground on Thursday as the market reacted to a major multi-year strategic collaboration with Merck aimed at accelerating AI-driven precision medicine. This deal, announced earlier this week, grants Merck access to Tempus’ massive multimodal datasets and GPU infrastructure to discover new biomarkers. Despite recent insider selling, investors are increasingly bullish on Tempus’ 2026 revenue guidance of $1.59 billion, viewing the Merck partnership as a key validation of its data-licensing business model.

MicroAlgo Inc (MLGO): $3.96 USD, +13.14% (+$0.46 USD), Technology/Quantum AI. MLGO shares surged on Thursday as momentum traders returned to the speculative “AI-Quantum” favorite. The rally follows continued retail interest in the company’s recent advancements in quantum-based game theory algorithms and a technical bounce from its 52-week lows. While the stock remains highly volatile, Thursday’s double-digit gain was fueled by a “stock-specific” momentum trigger, outperforming its close peers in the specialized algorithm sector.

Crowdstrike Holdings Inc (CRWD): $426.16 USD, +4.53% (+$18.48 USD), Cybersecurity/AI. CRWD shares rallied on Thursday as the market fully “digested” its blockbuster Q4 2026 earnings beat. The company achieved a historic milestone, becoming the first pure-play cyber firm to surpass $5 billion in Annual Recurring Revenue (ARR). Investors are cheering a 47% explosion in net-new ARR ($331M) and a fresh strategic partnership with Schwarz Digits to provide sovereign AI cloud security in Europe. Despite conservative Q1 guidance, the narrative has shifted to CrowdStrike’s role as “mission-critical” infrastructure in the AI era.

Xponential Fitness Inc (XPOF): $5.89 USD, +6.51% (+$0.36 USD), Consumer Discretionary. XPOF shares climbed on Thursday as investors reacted to an activist push by Voss Capital, which disclosed an 18.2% stake and called for a formal strategic review, including a potential sale of the company. This move is providing a much-needed tailwind after the stock was “obliterated” last week following a massive Q4 earnings miss and weak 2026 revenue guidance. The market is currently weighing Voss Capital’s argument that the Club Pilates brand alone is worth more than the company’s entire current enterprise value.

Daily Market Movers: US & Canada Top Movers (March 4, 2026)

Leverage Shares 2X Long GEMI Daily ETF (GEMG): $2.55 USD, +66.88% (+$1.02 USD), Leveraged Equity. GEMG is delivering exactly what it was designed for today—doubling the daily performance of its underlying asset, Gemini Space Station Inc (GEMI). As GEMI shares surged nearly 34% on a major technical rebound and pre-earnings speculation, this 2x leveraged ETF amplified those gains into a massive 67% “explosion.” While today is a win for the bulls, traders should note GEMG’s high expense ratio (0.75%) and the inherent decay risks of holding leveraged single-stock ETFs for more than a single trading session, especially given the underlying’s 125% implied volatility.

Texxon Holding Ltd (NPT): $14.90 USD, +44.94% (+$4.62 USD), Consumer Cyclical. Shares of the supply chain management firm are “exploding” today as they trade near 52-week highs ($15.50). The rally is being driven by a surge in “Strong Buy” technical signals and heavy trading volume exceeding 1 million shares. Investors are increasingly optimistic about the company’s expansion into major chemical and plastic projects in East China, specifically the milestones reached for its 600,000-ton Polystyrene project.

Babcock & Wilcox Enterprises Inc (BW): $11.80 USD, +45.68% (+$3.70 USD), Industrials. Babcock & Wilcox shares rocketed today after the company announced a massive $2.4 billion “full notice to proceed” for a 1.2 GW power project supporting Applied Digital’s AI data center campuses. This major contract win coincided with a swing to profitability in their Q4 results, signaling a fundamental shift toward high-growth AI infrastructure.

Moderna Inc (MRNA): $57.80 USD, +15.99% (+$7.97 USD), Healthcare. Moderna shares surged to a fresh 52-week high today as investors celebrated a global patent settlement with Arbutus Biopharma and Genevant Sciences. By agreeing to a $950 million upfront payment, Moderna has effectively removed a massive “litigation overhang” that had clouded the company’s financial future for years. Wall Street is viewing the deal as a major win, as it eliminates the risk of future royalties on Moderna’s entire infectious disease portfolio, including its next-gen COVID and flu combination shots.

Evolus Inc (EOLS): $5.59 USD, +35.35% (+$1.46 USD), Healthcare. Evolus shares are currently undergoing their largest intraday rally in nearly five years. The “explosion” follows a major fourth-quarter earnings report where the company posted its first quarterly net income since early 2021. Investors are cheering the “Botox-rival’s” ability to achieve profitability while maintaining double-digit revenue growth ($90.3 million for Q4). The stock is also being propelled by a fresh 2026 outlook that projects sustainable profitability and a new $30 million revolving credit facility, which de-risks the company’s expansion plans for its Evolysse and Estyme filler lines.

Bitfarms Ltd (BITF): $2.24 USD, +12.56% (+$0.25 USD), Financial Services/Technology. Bitfarms shares jumped today as the broader cryptocurrency mining sector rallied following a call for the passage of stalled crypto legislation. The stock’s double-digit gain is also being supported by positive investor sentiment regarding the company’s strategic pivot toward high-performance computing (HPC) and AI data center infrastructure, which is expected to diversify its revenue streams beyond Bitcoin mining.

SSR Mining Inc (SSRM): $45.32 CAD, +14.65% (+$5.79 CAD), Materials. SSR Mining shares hit a fresh 52-week high today after the company announced a binding agreement to sell its 80% stake in the Çöpler gold mine in Turkey to Cengiz Holding for $1.5 billion in cash. This strategic divestment follows a long period of operational suspension at the site due to a 2024 landslide. Investors are cheering the massive cash infusion, which significantly de-risks the company’s balance sheet and allows it to refocus its portfolio on its core assets in the Americas.

Gemini Space Station Inc (GEMI): $8.69 USD, +33.69% (+$2.19 USD), Financial Services/Technology. Gemini (the crypto exchange founded by the Winklevoss twins) is seeing a massive price reversal today. While I previously noted excitement over “orbital modules,” I should clarify—the “Space Station” in the name is part of their corporate branding; the surge is actually tied to their crypto and prediction markets platform. Traders are aggressively buying the dip following a brutal February that saw a 12% drop due to high-level executive departures. Today’s “explosion” is being fueled by heavy speculative volume ahead of their Q4 earnings report on March 19, as investors bet on a turnaround in their unit economics and international expansion.

CoreWeave Inc (CRWV): $79.50 USD, +7.75% (+$5.72 USD), Technology. CoreWeave shares surged today after the specialized cloud provider announced a multi-year strategic partnership with Perplexity to power its AI inference workloads. The move is being hailed as a major validation of CoreWeave’s “neocloud” infrastructure, helping the stock reclaim ground after a volatile February. With a massive $66.8 billion revenue backlog reported in their recent year-end results, investors are piling back in, viewing the recent dip as a buying opportunity for the fastest-growing cloud provider in history.

Nebius Group NV (NBIS): $97.78 USD, +12.65% (+$10.98 USD), Technology. Nebius Group shares charged higher today after the AI infrastructure specialist secured local government approval for its first “Gigawatt-scale” AI factory camp in Independence, Missouri. The deal, which includes a Chapter 100 industrial development incentive, marks a massive step in Nebius’s goal to reach $7–$9 billion in annualized revenue by the end of 2026. Institutional investors are viewing the 1.2 GW capacity expansion as a major competitive win against other “neocloud” providers, as it significantly scales their ability to offer GPU-as-a-Service at a massive global level.

IREN Ltd (IREN): $43.84 USD, +12.84% (+$4.99 USD), Technology/Energy. IREN shares are surging today as the market rewards the company’s massive leap in AI scale. The “explosion” follows an announcement that IREN has secured over 50,000 NVIDIA B300 GPUs, expanding its total fleet to 150,000 units. This aggressive procurement strategy is expected to drive AI Cloud annualized revenue to over $3.7 billion by the end of 2026. While the company previously faced pressure after a February earnings miss, investors are now focusing on its successful pivot from Bitcoin mining to becoming one of the world’s largest vertically integrated AI cloud platforms.

Intel Corp (INTC): $45.58 USD, +5.75% (+$2.48 USD), Technology. Intel shares jumped today as the market responded to highly optimistic commentary from CFO David Zinsner at a major technology conference. Zinsner revealed that demand for Intel’s processors is rising “meaningfully” in 2026, leading customers to seek multi-year supply agreements to get ahead of tight supply. More importantly, he confirmed that yields for the critical 18A manufacturing node are progressing ahead of schedule, allowing Intel to market the technology to external foundry customers much earlier than expected. This shift—from internal-only use to a viable third-party foundry service—is being viewed as a “watershed moment” for the company’s turnaround strategy under CEO Lip-Bu Tan.

Asustek Computer Inc (2357): 518.00 TWD, +3.60% (+18.00 TWD), Technology. ASUS shares gained ground today as the company continues to gain traction in the “AI PC” supercycle. The move is fueled by strong pre-order data for its new 2026 AI-powered ExpertBook and Zenbook lineups, which are expected to drive a significant margin recovery in the second half of the year. Investors are also positioning themselves ahead of the company’s Q4 earnings call (scheduled for March 10, 2026), where analysts expect an update on ASUS’s strategic partnership with NVIDIA to bring digital humans and advanced AI inference to the consumer market.

Battalion Oil Corp (BATL): $27.68 USD, +134.58% (+$15.88 USD), Energy. Battalion Oil shares more than doubled during intraday trading today, hitting a fresh 52-week high of $29.70 as momentum traders pounced on a new $15 million private placement deal. While the offering was priced at a significant discount of $5.50 per share, investors interpreted the capital infusion as a critical lifeline for the company’s Delaware Basin operations. Combined with a global surge in oil prices due to escalating Middle East supply risks, the news triggered an explosive short squeeze. With the stock now having more than tripled since last Friday, BATL has emerged as the primary high-beta play for traders seeking domestic energy exposure.

Empire Petroleum Corp (EP): $3.77 USD, +6.20% (+$0.22 USD), Energy. Empire Petroleum shares gained over 6% today, closing at $3.77 as the stock continues to build momentum from its late-February pivot point. The rally comes as the company recently modified and extended its registered rights offering to March 18, increasing potential proceeds to $10 million to bolster its balance sheet. Despite facing liquidity challenges earlier in the year, the stock has now risen three days in a row, with today’s intraday high reaching $4.00. Investors are increasingly viewing EP as a high-upside domestic play as the company secures the capital needed to develop its producing assets across the Permian and Bakken regions.

Mobix Labs Inc (MOBX): $1.12 USD, +532.77% (+$0.94 USD), Technology. Mobix Labs witnessed an explosive rally today, with shares surging over 500% to close at $1.12 on massive relative volume. The move follows a period of extreme penny-stock volatility and recent updates regarding their airborne sensing and drone-defense technology. As the stock regained critical price levels to address Nasdaq compliance concerns, it became the top percentage gainer across all major exchanges today, attracting intense interest from day traders looking to capitalize on its low-float dynamics and military-adjacent tech applications.

Ziff Davis Inc (ZD): $41.48 USD, +48.09% (+$13.47 USD), Technology. Ziff Davis shares skyrocketed today after the digital media and internet services giant reported Q4 earnings that shattered analyst expectations. The stock saw its highest single-day gain in years as investors cheered a surprise expansion in its advertising technology margins and a robust outlook for 2026. With the company successfully pivoting toward AI-integrated content platforms, ZD has become a standout performer in a tech sector that otherwise struggled with broader market volatility today.

Tidewater Inc (TDW): $87.67 USD, +9.77% (+$7.80 USD), Energy. Tidewater shares surged today as the offshore energy service provider capitalized on the spike in crude oil prices. As the Middle East conflict drives Brent and WTI higher, Tidewater’s fleet of offshore support vessels has seen increased utilization and higher day rates. The stock hit the upper end of its 52-week range today, reflecting institutional confidence in the prolonged “supercycle” for offshore oil and gas services.

Gartner Inc (IT): $164.78 USD, +3.36% (+$5.35 USD), Technology. Gartner shares surged today as investors responded enthusiastically to a fourth-quarter earnings beat, with EPS of $3.94 comfortably topping the $3.50 consensus estimate. Despite a broader decline in the S&P 500, the stock was bolstered by news of significant insider buying, notably a $9.94 million share purchase by Director Stephen Pagliuca. The company’s resilience in its research and advisory segments, combined with management’s focus on AI-powered tools like AskGartner, has helped the stock stabilize and outperform its tech peers following a challenging start to the year.

Plug Power Inc (PLUG): $2.23 USD, +23.20% (+$0.42 USD), Energy. Plug Power shares surged over 23% today as investors cheered a “triple-beat” quarter that signaled a potential turning point for the embattled hydrogen firm. The company reported Q4 revenue of $225.2 million—beating the $217 million estimate—while narrowing its per-share loss to just $0.06. Most significantly, Plug achieved a positive gross margin of 2.4% for the quarter, a massive leap from the deeply negative territory of the previous year. With new CEO Jose Luis Crespo officially taking the helm this week and a roadmap to positive EBITDA by late 2026, the stock saw a massive short-covering rally that defied the broader market sell-off.

Palantir Technologies Inc (PLTR): $147.22 USD, +1.41% (+$2.05 USD), Technology. Palantir shares extended their winning streak to five days, gaining 1.4% on Tuesday to close at $147.22. While the broader Nasdaq suffered a 1% decline due to escalating Middle East tensions, Palantir emerged as a primary “safe haven” for AI and defense capital. The stock was buoyed by a major price target hike from Rosenblatt Securities, which raised its target from $150 to $200, citing the “regrettable necessity” of Palantir’s software in modern warfare. Analysts increasingly view the company’s AI platforms, Foundry and Gotham, as superior alternatives to standard large language models (LLMs) for mission-critical military operations. Despite a mid-day dip to $138 as investors weighed broader war risks, the stock staged a robust recovery, bringing its cumulative five-day gain to 14% and its market capitalization to approximately $353 billion

AeroVironment Inc (AVAV): $228.30 USD, +9.59% (+$19.98 USD), Aerospace & Defense. AeroVironment shares rebounded sharply today, recovering nearly 10% after a volatile “pop-and-drop” session on Monday. The stock surged as the company clarified that it is in active negotiations with the U.S. Space Force to transition its $1.4 billion SCAR program to a firm-fixed-price structure, rather than losing the contract entirely. Investor sentiment was further bolstered by the announcement of a $30 million expansion of its manufacturing hub in Albuquerque, New Mexico, which is expected to create over 450 jobs and double its production capacity for space and directed-energy systems. Despite a recent analyst downgrade from Raymond James, the stock remains a primary beneficiary of the global “drone dominance” cycle and the heightened demand for domestic defense infrastructure.

Select Medical Holdings Corp (SEM): $16.26 USD, +8.40% (+$1.26 USD), Healthcare. Select Medical shares jumped over 8% today to close at $16.26 as the market adjusted to the news of a $3.9 billion take-private agreement. A consortium led by Executive Chairman Robert A. Ortenzio and Welsh, Carson, Anderson & Stowe (WCAS) has agreed to acquire all outstanding shares for $16.50 per share in cash. While several law firms announced investigations into the fairness of the deal—noting it sits below the stock’s 52-week high of $18.61—traders aggressively bid the price up toward the acquisition target. The deal, which includes no financing condition and a $133 million reverse termination fee, is expected to close by mid-2026, marking the end of SEM’s tenure on the NYSE.

Rocket Doctor AI Inc (AIDR): $0.64 CAD, +4.92% (+$0.03 CAD), Healthcare. Rocket Doctor AI shares gained nearly 5% today following the announcement of a major new contract with a top-tier New York State insurer. The deal expands the company’s “in-network” reach by an additional 2.4 million members, bringing its total covered lives in the U.S. to over 15 million across key markets like California and New York. Investors responded positively to this rapid expansion of the payer network, which allows eligible members to access Rocket Doctor’s AI-powered digital health platform and board-certified physician network with in-network benefits. This news follows a period of strong momentum for the Vancouver-based firm, which recently upsized its private placement to $5.2 million to fund its aggressive growth in the tele-health space.

📉 Top Losers – WebKarobar Daily Market Movers

Micron Technology Inc (MU): $379.68 USD, -7.99% (-$32.99 USD), Semiconductors. Micron shares tumbled nearly 8% today as a “perfect storm” of geopolitical and energy fears hit the semiconductor sector. The sell-off was triggered by a sharp decline in the South Korean KOSPI index, where memory giants Samsung and SK Hynix fell on fears of a global energy price shock. Investors are concerned that escalating conflict in the Middle East could disrupt liquefied natural gas (LNG) supplies, significantly raising operating costs for energy-intensive fabrication plants. Despite the drop, fundamental outlooks remain bullish ahead of Micron’s March 18 earnings report, with UBS analysts suggesting annual EPS could approach $85—nearly double the current consensus—due to the sold-out status of its High-Bandwidth Memory (HBM) through 2026.

Broadcom Inc (AVGO): $313.84 USD, -1.56% (-$4.98 USD), Semiconductors. Broadcom shares dipped nearly 2% today as investors braced for the company’s fiscal first-quarter earnings report, scheduled for release after the bell on Wednesday, March 4. Despite the slight decline, the stock showed resilience compared to peers like Micron (-8%), recovering from an intraday low of $307.40. Analysts are largely focused on Broadcom’s $73 billion AI backlog and its ability to maintain gross margins as lower-margin custom AI accelerators (XPUs) become a larger portion of the revenue mix. While HSBC lowered its price target to $450 today citing a “valuation reset” for AI firms, the firm maintained its Buy rating, anticipating that Broadcom will beat its $19.1 billion revenue guidance

Tesla Inc (TSLA): $392.43 USD, -2.70% (-$10.89 USD), Consumer Discretionary. Tesla shares fell nearly 3% today as a “risk-off” mood swept through high-growth stocks following the escalation of the U.S.-Iran conflict. Despite mixed February registration data from Europe—showing a massive 55% surge in France but an 18% decline in Denmark—the stock was unable to overcome the broader market’s energy-related jitters. Investor sentiment was also weighed down by a polarizing decision to tighten the eligibility for Full Self-Driving (FSD) transfers, requiring owners to take delivery of new vehicles by March 31 rather than just placing an order. While domestic oil price spikes structurally favor EV adoption, near-term concerns over supply chain disruptions and Tesla’s “dizzying” valuation relative to traditional automakers have kept the stock under pressure, now trading at its lowest level since November 2025

Intel Corp (INTC): $43.10 USD, -5.27% (-$2.40 USD), Technology. Intel shares tumbled over 5% today, closing at $43.10 as the semiconductor giant was hit by a “perfect storm” of geopolitical anxiety and executive leadership changes. The decline was fueled by the sudden escalation of the U.S.-Iran conflict and the shutdown of the Strait of Hormuz, which sparked fears of a global energy shock and rising manufacturing costs for power-intensive chip fabrication. Compounding the macroeconomic pressure, the company announced that Board Chair Frank D. Yeary will retire in May, with Dr. Craig H. Barratt set to succeed him. Despite recently launching its next-generation AI PC processors, Intel continues to underperform peers like AMD and Nvidia as investors weigh its heavy capital expenditure requirements against a backdrop of potential global supply chain disruptions and worsening inflation

Daily Market Movers: US & Canada Top Movers (March 2, 2026)

Lockheed Martin Corp (LMT): $676.48 USD, +3.34% (+$21.85 USD), Aerospace & Defense. Lockheed Martin shares hit a fresh all-time record of $692.00 during intraday trading today as the market reacts to the dramatic escalation of the U.S.-Iran conflict. Following over-the-weekend strikes by U.S. and Israeli forces, the stock has become the primary “safe haven” for institutional capital. With a year-to-date return now exceeding 36%, LMT is significantly outperforming the broader S&P 500 as the world enters a period of intensive rearmament. The company’s role as the manufacturer of the F-35 Lightning II and PAC-3 missile interceptors—both currently active in the Middle East theater—has cemented its status as a “mission-critical” asset for Western defense.

Astrana Health Inc (ASTH): $26.32 USD, +29.46% (+$5.99 USD), Healthcare / Medical Management. Astrana shares skyrocketed today after the company delivered a massive Q4 earnings beat, reporting adjusted EPS of $0.54 against analyst expectations of just $0.15. The surge is fueled by a 43% year-over-year revenue jump to $950.5 million, driven by the rapid expansion of its “value-based care” model, where the company takes on full financial risk for patient outcomes. Investors are particularly bullish on management’s 2026 outlook, which forecasts revenue climbing as high as $4.1 billion. The rally was further supported by news that the integration of Prospect Health is ahead of schedule and the Board’s decision to double its share repurchase authorization to $100 million.

Evolution Metals & Technologies Corp (EMAT): $10.16 USD, +27.48% (+$2.19 USD), Materials / Critical Minerals. EMAT shares surged today as the company continues to gain momentum following its January NASDAQ debut. The rally is primarily driven by its unique position as a vertically integrated alternative to China’s dominance in the rare earth magnet market. Recent interest has spiked following an investor webinar where management detailed the scale-up of its U.S.-based industrial campus and its 18-year track record of supplying magnets to tier-1 OEMs like Ford and Hyundai. Technical “buy” signals and a shift in analyst sentiment from “sell” to “buy” candidates have further accelerated the price action, with volume significantly outpacing the three-month average as investors bet on EMAT’s ability to capture the burgeoning demand for EV battery materials and defense-grade magnets.

Strategy Inc (MSTR): $137.65 USD, +6.29% (+$8.15 USD), Financial Services / Digital Assets. Strategy Inc (formerly MicroStrategy) is seeing a relief rally today as Bitcoin stabilizes around the $66,000 level following a period of extreme volatility. The stock is currently trading at a roughly 8% discount to its Net Asset Value (NAV), making it an attractive entry point for investors who view it as “Bitcoin on steroids.” The surge is further supported by the company’s proactive capital management; management recently increased the dividend rate for its STRC preferred stock to 11.50% for March 2026, signaling confidence in its “Digital Credit” strategy. Despite reporting a massive non-cash accounting loss in Q4 due to Bitcoin’s price drop, the company’s core software revenue actually exceeded expectations, growing to $123 million, providing a stable foundation for its aggressive treasury operations.

Ubiquiti Inc (UI): $798.47 USD, +4.10% (+$31.48 USD), Technology / Networking Equipment. Ubiquiti shares are pushing toward all-time highs today, fueled by continued momentum from its “blowout” Q2 2026 earnings report on February 6. The stock’s performance reflects a massive 35.8% year-over-year revenue surge to a record $814.9 million, driven by aggressive expansion in its Enterprise Technology segment. Investors are also cheering the company’s operational efficiency; gross margins expanded to 45.9% (up from 41.2%) despite global trade tensions and higher tariff costs. With a quarterly dividend of $0.80 per share recently paid on February 23, UI is currently acting as a high-growth momentum favorite in the wireless infrastructure sector.

Ocular Therapeutix Inc (OCUL): $10.98 USD, +22.82% (+$2.04 USD), Healthcare / Biotechnology. Ocular shares surged to a fresh multi-month high today following a high-profile investor webcast on March 2, where management broke down “landmark” Phase 3 data for their wet AMD drug, AXPAXLI. The stock’s momentum is driven by the SOL-1 superiority trial results, which showed that AXPAXLI was significantly more effective than the current standard of care, Eylea, at the 36-week mark ($p=0.0006$). Most impressively, 65.9% of patients maintained their vision through an entire year with just a single dose, a result CEO Pravin Dugel described as “best-in-disease” durability. With a massive $737 million cash reserve providing a runway into 2028 and plans to fast-track an FDA filing via the 505(b)(2) pathway, investors are betting OCUL could disrupt the multibillion-dollar retinal disease market.

HEALWELL AI Inc (AIDX): $0.74 CAD, +7.25% (+$0.05 CAD), Healthcare / Artificial Intelligence. HEALWELL shares are recovering today as the company transitions into a “pure-play” AI SaaS provider following its massive acquisition of Orion Health in 2025. The stock is currently trading near the bottom of its 52-week range ($0.58–$1.81) but is gaining momentum ahead of its Q4 2025 earnings report scheduled for March 26, 2026. The recent 7% uptick is driven by news of the company’s first major AI implementation in the Middle East, a governmental contract in Saudi Arabia to deploy its SMART Search and SMART Identify tools. With a 645% revenue surge reported in previous quarters and two consecutive quarters of positive Adjusted EBITDA, investors are eyeing the current $0.74 level as a potential bottom for the AI-driven healthcare specialist. As Iranian retaliatory strikes—including drone attacks reported near the U.S. Embassy in Riyadh and Saudi energy facilities—intensify, the demand for HEALWELL’s population intelligence and crisis-management AI is being viewed as a vital infrastructure tool.

AXT Inc (AXTI): $46.32 USD, +22.22% (+$8.42 USD), Technology / Semiconductor Materials. AXT Inc shares surged to a fresh multi-year high today as the company successfully navigates the “AI substrate” boom and easing geopolitical hurdles. The stock gapped up significantly following reports that the company has secured critical export permits from China’s Ministry of Commerce for its indium phosphide (InP) wafers, which are vital for the 800G and 1.6T optical transceivers used in AI data centers. This breakthrough follows a period of regulatory uncertainty that had previously restricted shipments. With a reinforced cash position of $128.4 million from a recent capital raise and plans to double its InP manufacturing capacity in the second half of 2026, AXT is being repriced as a primary “picks and shovels” play for the global AI infrastructure build-out.

Applied Optoelectronics Inc (AAOI): $102.51 USD, +21.70% (+$18.28 USD), Technology / Optical Networking. Applied Optoelectronics reached a new 8-year high today after crushing Q4 expectations and issuing “monster” guidance for 2026. The surge is driven by a massive ramp-up in demand for 800G optical transceivers—the hardware required to link AI chips in data centers. With hyperscale customers like Amazon and Oracle accelerating their AI infrastructure spend, the company projected that 2026 revenue will exceed $1 billion, a figure that would more than double its record 2025 results. CEO Thompson Lin noted that demand for these next-generation modules is expected to outpace the company’s production capacity well into 2027, prompting a major expansion of its Houston, Texas, manufacturing facility.

Palantir Technologies Inc (PLTR): $145.13 USD, +5.78% (+$7.94 USD), Technology / Software & AI. Palantir shares surged today, staging a sharp rebound as the company cements its role as the “AI Operating System” for Western defense. The rally is ignited by a combination of geopolitical tailwinds and massive contract wins, most notably a fresh five-year, $1 billion blanket purchase agreement with the Department of Homeland Security (DHS). This deal allows all DHS agencies to streamline their AI and data analytics rollout using Palantir’s Gotham and Foundry platforms. Investor confidence is further bolstered by the company’s recent Q4 “double beat,” which saw U.S. commercial revenue skyrocket 137% year-over-year. Despite a 20% year-to-date pullback in early 2026, analysts from Bank of America and UBS have recently reiterated “Buy” ratings, with price targets as high as $255, viewing the current price as a compelling entry point for the “clear winner” of the industrial AI revolution.

BigBear.ai Holdings Inc (BBAI): $4.10 USD, +3.54% (+$0.14 USD), Technology / Defense & Intelligence AI. As Iranian strikes target critical infrastructure in the UAE, BigBear.ai is emerging as a critical “resilience” play. The company’s recent expansion in Abu Dhabi and its focus on autonomous systems place it at the center of the UAE’s urgent need for predictive maintenance and real-time threat detection. While the physical strikes create regional volatility, they are simultaneously accelerating the adoption of BBAI’s AI-driven logistics and security platforms. Investors are betting that the UAE government will fast-track the deployment of BBAI’s CargoSeer and ConductorOS to safeguard supply chains and coordinate emergency response efforts as the “missile rain” impacts the region’s shipping and energy hubs.

NVIDIA Corp (NVDA): $182.37 USD, +2.93% (+$5.18 USD), Technology / Semiconductors. NVIDIA shares are trading higher today as the market digests last week’s “monster” Q4 earnings report and a fresh upgrade from Morgan Stanley, which named NVDA its top chip pick for 2026. The company recently reported staggering fiscal year 2026 revenue of $215.9 billion (up 65%), driven by the massive ramp-up of its Blackwell Ultra (GB300) architecture. Despite a slow start to the calendar year, the stock is regaining momentum as hyperscalers like Meta and Microsoft commit to $700 billion in total AI capex for 2026. CEO Jensen Huang confirmed that “agentic AI” has reached an inflection point, with the upcoming Vera Rubin platform already sampling to key customers ahead of its late-2026 launch.

Devon Energy Corp (DVN): $44.95 USD, +3.26% (+$1.42 USD), Energy / Oil & Gas Exploration. Devon Energy shares are outperforming the broader market today as investors react to the massive $58 billion merger with Coterra Energy, a deal that officially positions the combined company as a “Shale Titan” with a production capacity of 1.6 million barrels of oil equivalent per day. The rally is further supported by the current geopolitical “risk premium” on crude oil, which has helped DVN climb over 20% in the last 30 days. Despite reporting a year-over-year dip in Q4 EPS to $0.82 (matching estimates), the market is looking forward to the $1 billion in projected synergies from the Coterra tie-up and a business optimization plan designed to boost free cash flow by the end of 2026.

Occidental Petroleum Corp (OXY): $54.21 USD, +2.13% (+$1.13 USD), Energy / Oil & Gas Exploration. Occidental Petroleum shares are climbing today as the energy sector reacts to a spike in crude prices fueled by the U.S.-Israel military strikes against Iran. Beyond the geopolitical “risk premium,” OXY is benefiting from a strong Q4 2025 earnings report and an 8% dividend hike announced in February. The stock is being closely watched as it nears a critical technical breakout, having gapped higher following its earnings beat where production in the Permian Basin exceeded the high end of management’s guidance. Investors are also focused on the company’s massive deleveraging success; following the $9.7 billion sale of OxyChem to Berkshire Hathaway in late 2025, OXY has successfully reduced its principal debt to below its $15 billion target, significantly lowering interest expenses for 2026.

Trump Media & Technology Group Corp (DJT): $11.08 USD, +3.45% (+$0.37 USD), Technology / Social Media & Energy. DJT shares ticked higher today as the company continues its aggressive transition from a pure social media play into a diversified technology and energy conglomerate. The stock’s stability in 2026 is anchored by its late-2025 acquisition of nuclear-fusion specialist TAE Technologies, a $6 billion deal that has reframed the company as a “future energy” contender. While Truth Social remains its core platform for President Trump’s direct communication, investors are increasingly focused on the company’s upcoming distribution of shareholder cryptocurrency tokens in partnership with Crypto.com and its role in the “AI-energy nexus.” With nearly $2.2 billion in market cap, DJT is acting as a primary barometer for political sentiment as the administration navigates the ongoing Greenland framework and Middle East tensions.

📉 Top Losers – WebKarobar Daily Market Movers

Aardvark Therapeutics Inc (AARD): $5.47 USD, -56.20% (-$7.02 USD), Healthcare / Biotechnology. Aardvark shares were decimated today, losing more than half their value in a single session. The crash follows the company’s Friday after-hours announcement that it is voluntarily pausing its Phase 3 HERO trial for its lead drug candidate, ARD-101. The trial was evaluating the drug as a treatment for hyperphagia (insatiable hunger) in patients with Prader-Willi Syndrome (PWS). This “black swan” event has triggered a wave of analyst downgrades and effectively erased nearly all the gains made since the company’s 2025 IPO.

Ensysce Biosciences Inc (ENSC): $0.60 USD, -3.72% (-$0.023 USD), Healthcare / Biotechnology. Ensysce shares are under slight pressure today as the market digests the company’s recent announcement (Feb 25, 2026) that it has initiated a formal review of strategic alternatives. While such reviews can often lead to a buyout or lucrative licensing deals, they also signal to investors that the company may be seeking a “lifeline” to fund its ongoing Phase 3 clinical trials. Despite the small dip today, the stock remains a high-conviction play for those tracking the AI-driven safer opioid market, particularly as regional instability in the Middle East drives an urgent need for tamper-proof pain management for both military and civilian trauma.

Decent Holding Inc (DXST): $0.098 USD, -10.47% (-$0.012 USD), Industrials / Environmental Services. Decent Holding shares hit a fresh 52-week low today as the market reacts to the “red zone” financial health rating and the looming threat of an impending reverse stock split. Despite reporting a massive 147% revenue surge in its most recent mid-year results, the stock has plummeted over 90% since January. Investor sentiment has turned sharply bearish following the February 23 extraordinary general meeting, where shareholders approved broad authority for a major share consolidation to maintain Nasdaq compliance. With a market cap now hovering just above $4 million and warrants set to expire on March 12, the company is struggling to convince investors that its transition into high-margin microbial products can offset its current cash-transfer and regulatory risks in China.

Rivian Automotive Inc (RIVN): $15.01 USD, -2.09% (-$0.32 USD), Technology / Electric Vehicles. Rivian shares are cooling today as the market balances a Q4 earnings beat against a broader slowdown in the EV sector. While the company reported an adjusted loss of $0.66 per share (beating the $0.68 consensus), total revenue fell 25.8% year-over-year. All eyes are now on March 12, 2026, when Rivian will take the stage at the SXSW festival in Austin to launch the “Launch Edition” of the R2 SUV. This vehicle is seen as the make-or-break catalyst for the company; management expects it to drive a 53% jump in total deliveries for 2026, targeting a record volume of up to 67,000 units.